%PDF-1.3
%
2 0 obj
<>
endobj
9 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
1 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
8 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
10 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
15 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
5 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
7 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
6 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
3 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
4 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
16 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
11 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
12 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
14 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
13 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
17 0 obj
<>stream
2014-06-04T13:00:53+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2014-07-15T08:01:11-07:00
Acrobat Distiller 8.1.0 (Windows)
application/pdf
untitled
uuid:5e105d50-8251-4ccd-9885-ce4699f52d5b
uuid:ffdc8fa5-f87c-46b3-a2f4-4871cdc1a675
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
28 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 38 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
39 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
30 0 obj
<>stream
/GS1 gs
BT
/F8 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 1 k
0 Tc
0 Tw
[(skin)-384.5(contamination)-393.9(and)-384.6(minimize)-388.4(false-positive)-387.6(culture)-390.4(re-)]TJ
0 -1.1174 TD
[(sults.)-556(Greater)-559.3(symptomatology)-554.9(has)-557.2(been)-553.9(associated)-557(with)]TJ
0 -1.1116 TD
[(higher)-284.3(bacterial)-285.6(counts)-278.4(and/or)-284.3(pathogenic)-285.5(bacteria.)]TJ
7.3823 0 0 6.5614 263.3952 707.5841 Tm
(10)Tj
9.843 0 0 9.843 273.5432 703.2188 Tm
(\(III\))Tj
/F5 1 Tf
8.9663 0 0 8.9663 62.022 674.3621 Tm
(Management)Tj
/F11 1 Tf
0 -1.8336 TD
[(Effective)-335.8(milk)-336.5(removal)]TJ
/F8 1 Tf
9.843 0 0 9.843 72 641.4802 Tm
[(Because)-209(milk)-201.7(stasis)-209(is)-203.7(often)-202.6(the)-206.2(initiating)-203(factor)-210.6(in)-203.9(mastitis,)]TJ
-1.0137 -1.1174 TD
[(the)-188.9(most)-184.1(important)-185.5(management)-191.1(step)-184(is)-186.4(frequent)-189.8(and)-183(effective)]TJ
0 -1.1116 TD
[(milk)-282.4(removal:)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 72 604.403 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 80.9008 603.0991 Tm
[(Mothers)-343.7(should)-340.6(be)-343.2(encouraged)-343.9(to)-342.1(breastfeed)-343.8(more)-340.8(fre-)]TJ
T*
[(quently,)-335.1(starting)-332.7(on)-336.3(the)-332.9(affected)-341.8(breast.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 72 582.4628 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 80.9008 581.1589 Tm
[(If)-295.9(pain)-305.2(interferes)-302.5(with)-299.3(the)-304.1(let-down,)-302.5(feeding)-298.1(may)-305.2(begin)]TJ
T*
[(on)-583.9(the)-592.1(unaffected)-591.7(breast,)-588.2(switching)-593.9(to)-589.8(the)-586.3(affected)]TJ
T*
[(breast)-337.1(as)-331.5(soon)-332.5(as)-337.2(let-down)-339.4(is)-330.4(achieved.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 72 549.5809 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 80.9008 548.3337 Tm
[(Positioning)-248.4(the)-246.5(infant)-249.9(at)-251.2(the)-252.3(breast)-250.7(with)-247.4(the)-246.5(chin)-253.4(or)-244.1(nose)]TJ
0 -1.1174 TD
[(pointing)-446.9(to)-445.8(the)-448.1(blockage)-450.2(will)-449.2(help)-443.4(drain)-450.3(the)-448.1(affected)]TJ
0 -1.1116 TD
(area.)Tj
/F10 1 Tf
7.9702 0 0 7.9702 72 516.6991 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 80.9008 515.4518 Tm
[(Massaging)-289.4(the)-292.6(breast)-291.1(during)-288.9(the)-286.8(feed)-288.9(with)-293.5(an)-285.6(edible)-291.4(oil)]TJ
0 -1.1174 TD
[(or)-261.4(nontoxic)-269.4(lubricant)-266(on)-261.4(the)-263.8(ngers)-266.6(may)-264.9(also)-264.7(be)-268.3(helpful)]TJ
0 -1.1116 TD
[(to)-284.6(facilitate)-292.7(milk)-288.1(removal.)-285.5(Massage,)-291.6(by)-284.4(the)-286.8(mother)-291.3(or)-284.4(a)]TJ
T*
[(helper,)-674.8(should)-680.4(be)-671.5(directed)-680.7(from)-679.4(the)-672.7(blocked)-678.3(area)]TJ
0 -1.1174 TD
[(moving)-330.5(toward)-337(the)-338.7(nipple.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 72 461.9337 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 80.9008 460.6298 Tm
[(After)-451.1(the)-448.1(feeding,)-451.3(expressing)-450.8(milk)-449.4(by)-445.7(hand)-449.1(or)-445.7(pump)]TJ
0 -1.1116 TD
[(may)-431.9(augment)-437.6(milk)-432.1(drainage)-438.6(and)-430.7(hasten)-435.1(resolution)-438.6(of)]TJ
T*
[(the)-332.9(problem.)]TJ
7.3823 0 0 6.5614 131.6409 443.1117 Tm
(11)Tj
9.843 0 0 9.843 142.2992 438.7463 Tm
(\(III\))Tj
-7.142 -1.6703 TD
[(An)-319.9(alternate)-325.9(approach)-329.1(for)-320(a)-324.8(swollen)-320.8(breast)-325.6(is)-318.9(uid)-326.9(mobi-)]TJ
-1.0137 -1.1174 TD
[(lization,)-412.5(which)-405.1(aims)-409.9(to)-405.5(promote)-407.6(uid)-407.6(drainage)-409.8(toward)-406.2(the)]TJ
0 -1.1116 TD
[(axillary)-213.1(lymph)-214.2(nodes.)]TJ
7.3823 0 0 6.5614 147.0614 404.7306 Tm
(12)Tj
9.843 0 0 9.843 156.5291 400.3652 Tm
[(The)-213(mother)-210.7(reclines,)-217.4(and)-211.8(gentle)-210.8(hand)]TJ
-9.6014 -1.1116 TD
[(motions)-262.4(start)-265.9(stroking)-262.3(the)-263.8(skin)-257.8(surface)-270.1(from)-259(the)-263.8(areola)-263.6(to)-261.5(the)]TJ
0 -1.1174 TD
(axilla.)Tj
7.3823 0 0 6.5614 86.5134 382.7904 Tm
(12)Tj
9.843 0 0 9.843 96.6614 378.4251 Tm
(\(III\))Tj
-2.5055 -1.1116 TD
[(There)-394.9(is)-399.6(no)-393.9(evidence)-399.5(of)-399.6(risk)-396(to)-394(the)-396.3(healthy,)-399.6(term)-398.5(infant)]TJ
-1.0137 -1.1116 TD
[(of)-428.4(continuing)-427.3(breastfeeding)-433.7(from)-426(a)-428.5(mother)-429.6(with)-426(mastitis.)]TJ
7.3823 0 0 6.5614 297.4109 360.907 Tm
(7)Tj
9.843 0 0 9.843 62.022 345.5432 Tm
[(Women)-453.7(who)-459.2(are)-454.8(unable)-452.6(to)-457.3(continue)-454.9(breastfeeding)-462.5(should)]TJ
T*
[(express)-395.5(the)-390.5(milk)-386(from)-391.5(breast)-394.7(by)-388.1(hand)-391.5(or)-388.1(pump,)-389.2(as)-394.8(sudden)]TJ
T*
[(cessation)-335.8(of)-324.7(breastfeeding)-335.8(leads)-330.3(to)-330.6(a)-330.6(greater)-328(risk)-332.6(of)-330.5(abscess)]TJ
0 -1.1174 TD
[(development)-287.8(than)-276.4(continuing)-283.3(to)-284.6(feed.)]TJ
7.3823 0 0 6.5614 210.5574 317.0834 Tm
(11)Tj
9.843 0 0 9.843 220.7054 312.6613 Tm
(\(III\))Tj
/F11 1 Tf
8.9663 0 0 8.9663 62.022 283.8046 Tm
[(Supportive)-338.3(measures)]TJ
/F8 1 Tf
9.843 0 0 9.843 72 267.3637 Tm
[(Rest,)-453.5(adequate)-451.3(uids,)-452.2(and)-453.7(nutrition)-448.1(are)-454.8(important)-450.4(mea-)]TJ
-1.0137 -1.1116 TD
[(sures.)-199.8(Practical)-199.1(help)-201.5(at)-199.3(home)-196.9(may)-195.8(be)-199.2(necessary)-204.2(for)-193.3(the)-200.4(mother)]TJ
0 -1.1174 TD
[(to)-278.8(obtain)-273(adequate)-284.3(rest.)-273.8(Application)-280.8(of)-278.6(heatfor)-277.3(example,)-280.9(a)]TJ
0 -1.1116 TD
[(shower)-244.6(or)-238.3(a)-238.4(hot)-239.6(packto)-241.7(the)-235(breast)-245(just)-240.6(prior)-236(to)-238.5(feeding)-240.5(may)]TJ
T*
[(help)-224.6(with)-218.6(the)-223.5(let-down)-224.2(and)-217.6(milk)-224.8(ow.)-220.6(After)-220.7(a)-221.1(feeding)-229(or)-215.3(after)]TJ
0 -1.1174 TD
[(milk)-230.5(is)-232.5(expressed)-237.6(from)-230.2(the)-235(breasts,)-232(cold)-236.1(packs)-232.3(can)-230.3(be)-233.7(applied)]TJ
0 -1.1116 TD
[(to)-278.8(the)-281.1(breast)-285.3(in)-278.8(order)-283.1(to)-278.8(reduce)-286.5(pain)-282.2(and)-280.9(edema.)]TJ
1.0137 -1.1116 TD
[(Although)-361.3(most)-362.7(women)-365.9(with)-362.6(mastitis)-362.7(can)-362.7(be)-366.2(managed)-363.8(as)]TJ
-1.0137 -1.1174 TD
[(outpatients,)-548.1(hospital)-545.8(admission)-547.8(should)-548(be)-544.8(considered)-550.1(for)]TJ
0 -1.1116 TD
[(women)-227.6(who)-223(are)-224.5(ill,)-220.2(require)-229(intravenous)-221.8(antibiotics,)-225.7(and/or)-226.7(do)]TJ
T*
[(not)-308.7(have)-306.2(supportive)-306(care)-307.4(at)-308.8(home.)-304(Rooming-in)-307.3(of)-307.4(the)-309.9(infant)]TJ
T*
[(with)-535.4(the)-540.2(mother)-533.2(is)-537.8(mandatory)-537.7(so)-531.9(that)-541.5(breastfeeding)-537.4(can)]TJ
0 -1.1174 TD
[(continue.)-227.9(In)-221(some)-225.5(hospitals,)-227.6(rooming-in)-225.6(may)-218.8(require)-229(hospital)]TJ
0 -1.1116 TD
[(admission)-282.9(of)-278.6(the)-286.8(infant.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 95.0173 Tm
[(Pharmacologic)-337.3(management)]TJ
/F8 1 Tf
9.843 0 0 9.843 72 78.5763 Tm
[(Although)-545.6(lactating)-549.6(women)-544.4(are)-547(often)-542.4(reluctant)-549.4(to)-543.7(take)]TJ
-1.0137 -1.1116 TD
[(medications,)-337.3(women)-331.3(with)-328.1(mastitis)-333.9(should)-334.8(be)-331.7(encouraged)-332.4(to)]TJ
0 -1.1174 TD
[(take)-283.3(appropriate)-286.5(medications)-282(as)-279.6(indicated.)]TJ
/F2 1 Tf
8.9663 0 0 8.9663 323.0361 725.7825 Tm
(Analgesia.)Tj
/F8 1 Tf
9.843 0 0 9.843 373.6629 725.7825 Tm
[(Analgesia)-308.1(may)-299.4(help)-305.2(with)-305(the)-304.1(let-down)-304.8(reex)]TJ
-6.1571 -1.1116 TD
[(and)-269.4(should)-271.5(be)-268.3(encouraged.)-272.5(An)-268(anti-inammatory)-271.5(agent)-272.9(such)]TJ
0 -1.1174 TD
[(as)-325.7(ibuprofen)-322.2(may)-322.5(be)-320.1(more)-323.5(effective)-325.8(in)-319.1(reducing)-322.3(the)-321.4(inam-)]TJ
0 -1.1116 TD
[(matory)-297.1(symptoms)-287.5(than)-293.7(a)-290.2(simple)-291.3(analgesic)-296.9(like)-288.1(paracetamol/)]TJ
T*
[(acetamino)-10.3(phen.)-320(Ibuprofen)-322(is)-318.9(not)-320.2(detected)-324.7(in)-319.1(breastmilk)-325.7(fol-)]TJ
0 -1.1174 TD
[(lowing)-330.3(doses)-328.8(up)-324.7(to)-324.9(1.6)-166.9(g/day)-329.3(and)-327(is)-324.7(regarded)-334.8(as)-325.7(compatible)]TJ
0 -1.1116 TD
[(with)-282(breastfeeding.)]TJ
7.3823 0 0 6.5614 389.0834 664.384 Tm
(13)Tj
9.843 0 0 9.843 399.2314 660.0187 Tm
(\(III\))Tj
/F2 1 Tf
8.9663 0 0 8.9663 323.0361 638.0786 Tm
(Antibiotics.)Tj
/F8 1 Tf
9.843 0 0 9.843 375.2503 638.0786 Tm
[(If)-405.3(symptoms)-402.7(of)-405.3(mastitis)-403(are)-403(mild)-403.3(and)-407.6(have)]TJ
-6.3184 -1.1116 TD
[(been)-392.6(present)-390.1(for)-389.1(less)-391.2(than)-385.8(24)-388.1(hours,)-388.9(conservative)-392.3(manage-)]TJ
T*
[(ment)-266.1(\(effective)-263.5(milk)-259.3(removal)-264.8(and)-263.7(supportive)-259.9(measures\))-267.6(may)]TJ
T*
[(be)-360.5(sufcient.)-355.4(If)-353.5(symptoms)-356.6(are)-356.9(not)-354.8(improving)-351.2(within)-359.2(1224)]TJ
0 -1.1174 TD
[(hours)-402.7(or)-399.6(if)-394(the)-402(woman)-400.4(is)-393.8(acutely)-403.1(ill,)-398.8(antibiotics)-400.8(should)-398.2(be)]TJ
0 -1.1116 TD
[(starte)-9(d.)]TJ
7.3823 0 0 6.5614 341.9149 587.6786 Tm
(7)Tj
9.843 0 0 9.843 347.8109 583.3132 Tm
[(Worldwide,)-225.2(the)-223.5(most)-224.4(common)-223.3(pathogen)-224.4(in)-227(infective)]TJ
-3.5307 -1.1116 TD
[(masti)-8(tis)-205(is)-203.7(penicillin-resistant)]TJ
/F4 1 Tf
11.8938 0 TD
[(S.)-206.1(aureus)]TJ
/F8 1 Tf
3.6747 0 TD
(.)Tj
7.3823 0 0 6.5614 468.7369 576.7368 Tm
(14,15)Tj
9.843 0 0 9.843 487.3889 572.3715 Tm
[(Less)-208(commonly,)]TJ
-17.7111 -1.1174 TD
[(the)-367.5(organism)-362.4(is)-359.2(a)]TJ
/F4 1 Tf
7.5222 0 TD
(Streptococcus)Tj
/F8 1 Tf
5.9901 0 TD
(or)Tj
/F4 1 Tf
1.1923 0 TD
[(Escherichia)-368(coli)]TJ
/F8 1 Tf
6.664 0 TD
(.)Tj
7.3823 0 0 6.5614 525.8267 565.7952 Tm
(11)Tj
9.843 0 0 9.843 536.8251 561.3731 Tm
(The)Tj
-22.7336 -1.1116 TD
[(prefer)-8.8(red)-292.4(antibiotics)-302.9(are)-293.6(usually)-296.9(penicillinase-res)-13.2(istant)-295.9(peni-)]TJ
T*
(cillins,)Tj
7.3823 0 0 6.5614 339.7605 543.855 Tm
(5)Tj
9.843 0 0 9.843 348.2645 539.4896 Tm
[(such)-489.2(as)-492.7(dicloxacillin)-490.9(or)-491.7(ucloxacillin)-496.4(500)-164.6(mg)-487.2(by)]TJ
-3.5768 -1.1174 TD
[(mouth)-433.1(four)-424.8(times)-428.4(per)-430.6(day,)]TJ
7.3823 0 0 6.5614 422.2487 532.9133 Tm
(16)Tj
9.843 0 0 9.843 433.8708 528.4912 Tm
[(or)-428.4(as)-429.4(recommended)-428.1(by)-428.4(local)]TJ
-12.2739 -1.1116 TD
[(antibiotic)-359.6(sensitivities.)-360.1(\(III\))-356.7(First-generation)-355.2(cephalosporins)]TJ
T*
[(are)-276.3(also)-270.4(generally)-278.6(acceptable)-271.7(as)-273.9(rst-line)-276(treatment,)-271.9(but)-274.1(may)]TJ
T*
[(be)-331.7(less)-333.6(preferred)-330.1(because)-334.7(of)-324.7(their)-335.2(broader)-326.8(spectrum)-334.8(of)-330.5(cov-)]TJ
0 -1.1174 TD
[(erage)-9(.)-279.9(\(III\))]TJ
1.0137 -1.1116 TD
[(Cephalexin)-298(is)-295.9(usually)-291.2(safe)-294.5(in)-296.1(women)-291(with)-293.5(suspected)-301.1(pen-)]TJ
-1.0137 -1.1116 TD
[(icillin)-309(allergy,)-307.4(but)-308.7(clindamycin)-311(is)-301.6(suggested)-311.5(for)-308.5(cases)-308.1(of)-301.7(se-)]TJ
0 -1.1174 TD
[(vere)-277.4(penicillin)-278.9(hypersensitivity.)]TJ
7.3823 0 0 6.5614 438.4629 456.1511 Tm
(16)Tj
9.843 0 0 9.843 448.5542 451.7857 Tm
[(\(III\))-276.1(Dicloxacillin)-278.6(appears)]TJ
-13.7657 -1.1116 TD
[(to)-301.8(ha)19.7(ve)-302.9(a)-313.3(l)0(o)20.7(w)0(e)18.8(r)-312.1(ra)19.7(te)-303(of)-301.7(ad)19.7(ve)19.7(rs)21.1(e)-313.3(h)0(e)19.7(p)0(a)19.7(t)0(i)14.8(c)-307.5(ev)19.7(en)13.9(ts)-301.6(th)20.7(an)-297.1(u)15.2(cl)19.5(ox)20.8(a-)]TJ
T*
[(ci)13.8(ll)20.6(in)20.7(.)]TJ
7.3823 0 0 6.5614 335.2818 434.2676 Tm
-.0162 Tc
(17)Tj
9.843 0 0 9.843 345.5999 429.9023 Tm
0 Tc
[(Ma)18.8(ny)-295.9(au)19.7(th)15(or)20.9(it)20.6(ie)19.5(s)-311.9(r)0(e)19.7(c)0(o)19.7(m)0(m)18.4(e)0(n)19.7(d)-306.4(a)-307.5(1)0(0)20.8()0(1)15.1(4)0(-)20.9(d)0(a)19.7(y)-306.4(co)19.7(ur)15.1(se)-296.9(of)]TJ
-3.3061 -1.1174 TD
[(an)13.9(ti)20.6(bi)20.7(ot)20.7(ic)19.5(s)]TJ
7.3823 0 0 6.5614 353.2534 423.3259 Tm
-.0162 Tc
[(18)-16.2(,)11.9(1)-16.2(9)]TJ
9.843 0 0 9.843 369.3542 418.9038 Tm
0 Tc
[(;)-404.4(h)0(o)15.1(w)0(e)18.8(v)0(e)19.7(r)-404.2(th)20.7(is)-393.8(re)19.7(co)19.7(mm)18.4(en)19.7(da)13.9(ti)20.6(on)-393.9(ha)19.7(s)-404.1(n)0(o)20.8(t)-404.4(be)19.7(en)]TJ
-5.7194 -1.1116 TD
[(su)15.3(bj)20.7(ec)18.5(te)19.6(d)-271.8(t)0(o)-261.5(c)0(o)19.7(n)0(t)20.7(r)0(o)20.9(l)0(l)20.6(e)0(d)-262.5(t)0(r)20.7(i)0(a)13.8(l)0(s)20.9(.)-268.4(\(I)20.9(II)15.1(\))]TJ
/F4 1 Tf
1.0137 -1.1116 TD
[(S.)-545.9(aureus)]TJ
/F8 1 Tf
4.5617 0 TD
[(resistant)-553.6(to)-549.5(penicillinase-resistant)-556.8(penicillins)]TJ
-5.5754 -1.1174 TD
[(\(methicillin-resi)-12.5(stant)]TJ
/F4 1 Tf
8.7087 0 TD
[(S.)-327.1(aureus)]TJ
/F8 1 Tf
4.1239 0 TD
[([MRSA],)-335.2(also)-328(referred)-334.7(to)-324.9(as)]TJ
-12.8326 -1.1116 TD
[(oxaci)-8(llin-resistant)]TJ
/F4 1 Tf
7.5395 0 TD
[(S.)-338.6(aureus)]TJ
/F8 1 Tf
3.8072 0 TD
[(\))-340.9(has)-338.3(been)-340.8(increasingly)-339.4(isolated)]TJ
-11.3466 -1.1116 TD
[(in)-428.5(cases)-429.1(of)-422.6(mastitis)-431.8(and)-424.9(breast)-429.3(abscesses.)]TJ
7.3823 0 0 6.5614 483.7038 368.5038 Tm
(2022)Tj
9.843 0 0 9.843 506.381 364.1385 Tm
[(\(II-2\))-426.9(Clin-)]TJ
-19.6406 -1.1116 TD
[(icians)-297(should)-288.8(be)-291.3(aware)-292.1(of)-290.2(the)-292.6(likelihood)-289.2(of)-290.1(this)-292.5(occurring)-288.8(in)]TJ
0 -1.1174 TD
[(their)-346.7(community)-342.1(and)-338.5(should)-340.6(order)-340.7(a)-342.1(breastmilk)-343(culture)-344.3(and)]TJ
0 -1.1116 TD
[(assay)-289.7(of)-284.4(antibiotic)-290.5(sensitivities)-287.5(when)-288.7(mastitis)-287.8(is)-284.4(not)-285.7(improv-)]TJ
T*
[(ing)-383.6(48)-376.6(hours)-379.7(after)-382.3(starting)-378.8(rst-line)-385.4(treatment.)-381.3(Local)-383.5(resis-)]TJ
0 -1.1174 TD
[(tance)-700.3(patterns)-702.3(for)-694.4(MRSA)-698.2(should)-697.7(be)-700.3(considered)-699.8(when)]TJ
0 -1.1116 TD
[(choosi)-7.7(ng)-468.7(an)-469.9(antibiotic)-474.8(for)-475.5(such)-471.9(unresponsive)-476(cases)-475.1(while)]TJ
T*
[(culture)-419.2(results)-417.6(are)-420.3(pending.)-415.6(MRSA)-416(may)-420.4(be)-412.3(a)-417(community-)]TJ
0 -1.1174 TD
[(acqui)-8(red)-396.1(organism)-397(and)-396.1(has)-395.9(been)-398.4(reported)-397.1(to)-399.7(be)-395(a)-393.9(frequent)]TJ
0 -1.1116 TD
[(pathogen)-397.2(in)-399.7(cases)-394.5(of)-393.8(breast)-400.5(abscess)-396.5(in)-394(some)-398.3(communities,)]TJ
T*
[(particularl)-10.3(y)-300.6(i)0(n)-307.6(the)-304.1(United)-302.6(States)-308.3(and)-304(Taiwan.)]TJ
7.3823 0 0 6.5614 493.2282 258.9165 Tm
[(21,2)-8.6(3,24)]TJ
9.843 0 0 9.843 522.1416 254.5511 Tm
[(\(I,)-305.1(II-2\))]TJ
-21.2418 -1.1116 TD
[(At)-406.4(this)-407.6(time,)-402.1(MRSA)-410.2(occurrence)-408.4(is)-405.3(low)-401.7(in)-405.5(other)-404.2(countries,)]TJ
0 -1.1174 TD
[(such)-189.7(as)-187.5(the)-188.9(United)-193.2(Kingdom.)]TJ
7.3823 0 0 6.5614 425.3668 236.9763 Tm
(25)Tj
9.843 0 0 9.843 434.6077 232.611 Tm
[(\(I\))-187.5(Most)-189.6(strains)-187.3(of)-186.5(methicillin-)]TJ
-12.3488 -1.1116 TD
[(resistant)-542.1(staphylococci)-543.3(are)-535.5(susceptible)-545.5(to)-532.2(vancomycin)-540(or)]TJ
T*
[(trimethopri)-9.2(m/sulfamethoxazole)-391.3(but)-383.6(may)-385.8(not)-383.6(be)-389.3(susceptible)]TJ
0 -1.1174 TD
[(to)-301.8(rifampin.)]TJ
7.3823 0 0 6.5614 360.2267 204.0944 Tm
(26)Tj
9.843 0 0 9.843 370.5448 199.729 Tm
[(Of)-296.8(note)-299.4(is)-295.9(that)-299.6(MRSA)-300.8(should)-300.3(be)-297.1(presumed)-300.1(to)]TJ
-5.8403 -1.1116 TD
[(be)-452.6(resistant)-449.9(to)-445.8(treatment)-452.7(with)-449(macrolides)-453.5(and)-448(quinolones,)]TJ
T*
[(regardless)-290.6(of)-278.6(susceptibility)-283.1(testing)-285.5(results.)]TJ
7.3823 0 0 6.5614 479.5652 182.211 Tm
(27)Tj
9.843 0 0 9.843 489.7133 177.8456 Tm
(\(III\))Tj
-16.9335 -1.1174 TD
[(As)-354.2(with)-351.1(other)-352.3(uses)-356.5(of)-347.7(antibiotics,)-358.2(repeated)-353.4(courses)-355.2(place)]TJ
-1.0137 -1.1116 TD
[(women)-492.6(at)-487.3(increased)-498.3(risk)-488.1(for)-487.1(breast)-492.7(and)-488.3(vaginal)]TJ
/F4 1 Tf
20.8444 0 TD
(Candida)Tj
/F8 1 Tf
-20.8444 -1.1116 TD
(infections.)Tj
7.3823 0 0 6.5614 354.5007 149.3291 Tm
[(28,2)-8.6(9)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 313.0582 116.8441 Tm
(Follow-Up)Tj
/F8 1 Tf
9.843 0 0 9.843 323.0361 100.4031 Tm
[(Clinical)-415.9(response)-408.1(to)-411.3(the)-407.8(above)-411(management)-415.7(is)-411.1(typically)]TJ
-1.0137 -1.1116 TD
[(rapid)-208.4(and)-200.3(dramatic.)-207.3(If)-203.7(the)-200.4(symptoms)-206.9(of)-198(mastitis)-207.2(fail)-201.6(to)-203.9(resolve)]TJ
T*
[(within)-416.8(several)-414.3(days)-414.3(of)-411.1(appropriate)-413.2(management,)-419.1(including)]TJ
0 -1.1174 TD
[(antibiotics,)-502.1(a)-497.6(wider)-503(differential)-500.9(diagnosis)-500.5(should)-496.1(be)-498.7(con-)]TJ
0 -1.1116 TD
[(sidere)-8.8(d.)-384.7(Further)-388.9(investigations)-392.4(may)-385.8(be)-389.3(required)-385.6(to)-388.2(conrm)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(240)Tj
46.3849 0 TD
[(ABM)-336(PROTOCOL)]TJ
ET
endstream
endobj
40 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 44 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
45 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
41 0 obj
<>stream
/GS1 gs
BT
/F8 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 1 k
0 Tc
0 Tw
[(resistant)-282.9(bacteria,)-276.3(abscess)-281.3(formation,)-275.1(an)-279.8(underlying)-277.4(mass,)-274.8(or)]TJ
0 -1.1174 TD
[(inammatory)-368.3(or)-365(ductal)-366.3(carcinoma.)-370.7(More)-369.3(than)-362.8(two)-367.2(or)-365(three)]TJ
0 -1.1116 TD
[(recurrences)-345.9(in)-342.1(the)-338.7(same)-341.8(location)-339.8(also)-339.6(warrant)-339.3(evaluation)-343.2(to)]TJ
T*
[(rule)-282.1(out)-279.9(an)-285.6(underlying)-283.1(mass)-277.1(or)-284.4(other)-283.2(abnormality.)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 670.3369 Tm
(Complications)Tj
/F11 1 Tf
0 -1.8336 TD
[(Early)-336(cessation)-332.9(of)-336.7(breastfeeding)]TJ
/F8 1 Tf
9.843 0 0 9.843 69.7323 637.455 Tm
[(Mastitis)-264.4(may)-259.1(produce)-257.7(overwhelming)-265.5(acute)-256.8(symptoms)-264.4(that)]TJ
-1.0137 -1.1116 TD
[(prompt)-405.4(women)-406.2(to)-405.5(consider)-402.7(cessation)-410.7(of)-399.6(breastfeeding.)-408.3(Ef-)]TJ
T*
[(fective)-264.8(milk)-259.3(removal,)-262.5(however,)-256.2(is)-261.3(the)-258(most)-259(important)-260.3(part)-259.1(of)]TJ
0 -1.1174 TD
(treatment.)Tj
7.3823 0 0 6.5614 99.6661 608.9951 Tm
(7)Tj
9.843 0 0 9.843 107.6598 604.5731 Tm
[(Acute)-446.6(cessation)-439.5(of)-439.9(breastfeeding)-445.2(may)-437.7(actually)]TJ
-4.8669 -1.1116 TD
[(exacerbate)-323.4(the)-315.6(mastitis)-316.6(and)-315.5(increase)-318.6(the)-321.4(risk)-315.3(of)-313.2(abscess)-315.9(for-)]TJ
T*
[(mation;)-609.5(therefore,)-604.4(effective)-613.8(treatment)-608.2(and)-603.5(support)-606.6(from)]TJ
T*
[(healthcare)-374.2(providers)-373.8(and)-367.3(family)-372.1(are)-368.5(important)-375.5(at)-366.4(this)-367.3(time.)]TJ
0 -1.1174 TD
[(Mothers)-349.5(may)-351.3(need)-346.6(reassurance)-351.5(that)-345.6(the)-350.2(antibiotics)-349(they)-345.5(are)]TJ
0 -1.1116 TD
[(taking)-284.5(are)-282.1(safe)-283(to)-278.8(use)-280.7(during)-283.2(breastfeeding.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 527.8676 Tm
(Abscess)Tj
/F8 1 Tf
9.843 0 0 9.843 69.7323 511.4266 Tm
[(If)-284.4(a)-284.5(well-dened)-287.3(area)-284.3(of)-284.4(the)-286.8(breast)-285.3(remains)-287.6(hard,)-279.7(red,)-284.3(and)]TJ
-1.0137 -1.1116 TD
[(tender)-556.2(despite)-551.5(appropriate)-557.2(management,)-551.6(then)-552.9(an)-550.5(abscess)]TJ
T*
[(should)-225.4(be)-222.2(suspected.)-229.7(This)-224.4(occurs)-227.6(in)-221.2(about)-225.7(3%)-222.1(of)-221(women)-227.6(with)]TJ
0 -1.1174 TD
(mastitis.)Tj
7.3823 0 0 6.5614 92.9763 482.9668 Tm
(30)Tj
9.843 0 0 9.843 104.5417 478.5447 Tm
[(\(II-2\))-421.1(The)-420.4(initial)-424.2(systemic)-426.9(symptoms)-420(and)-424.9(fever)]TJ
-4.5502 -1.1116 TD
[(may)-575.9(have)-571.2(resolved.)-573.2(A)-566.4(diagnostic)-572.2(breast)-573.3(ultrasound)-576.7(will)]TJ
T*
[(identify)-436.5(a)-434.2(collection)-435.5(of)-434.1(uid.)-434(The)-431.9(collection)-441.2(can)-431.8(often)-433(be)]TJ
T*
[(drained)-194.4(by)-186.5(needle)-188.8(aspiration,)-189.7(which)-192(itself)-186.5(can)-189.9(be)-187.7(diagnostic)-192.1(as)]TJ
0 -1.1174 TD
[(well)-490.5(as)-492.7(therapeutic.)-492.9(Serial)-492.8(needle)-488.3(aspirations)-492.5(may)-489.5(be)-487.2(re-)]TJ
0 -1.1116 TD
(quired.)Tj
7.3823 0 0 6.5614 87.4771 428.1448 Tm
(3133)Tj
9.843 0 0 9.843 109.4173 423.7794 Tm
[(\(III\))-350.9(Ultrasound)-358.7(guidance)-352.3(for)-354.6(needle)-355.8(aspiration)]TJ
-5.0455 -1.1116 TD
[(may)-184.2(be)-187.7(necessary)-186.9(in)-180.9(some)-185.2(cases.)-190.6(Fluid)-184.2(or)-180.7(pus)-187.4(aspirated)-186.2(should)]TJ
0 -1.1174 TD
[(be)-516(sent)-518.1(for)-515.9(culture.)-514.8(Consideration)-518.9(of)-514.8(resistant)-519.1(organisms)]TJ
0 -1.1116 TD
[(should)-271.5(also)-264.7(be)-268.3(given)-266(depending)-271.6(on)-261.4(the)-269.5(incidence)-268.3(of)-267.1(resistant)]TJ
T*
[(organisms)-323(in)-319.1(that)-316.8(particular)-320.1(environment.)-324.6(Surgical)-316.5(drainage)]TJ
0 -1.1174 TD
[(may)-316.7(be)-308.6(necessary)-313.7(if)-313.3(the)-309.9(abscess)-315.9(is)-313.2(very)-310.8(large)-313.2(or)-313.2(if)-307.6(there)-313.2(are)]TJ
0 -1.1116 TD
.0116 Tc
[(mu)4.7(lt)4.6(ipl)4.6(e)-388.1(abs)4.9(c)-2.2(esses.)-383.5(After)-381.1(s)-.8(ur)4.8(gi)]TJ
12.9881 0 TD
.01 Tc
[(c)-3.8(a)2(l)-388.6(d)3.1(ra)-3.8(inage,)-385.1(bre)-3.8(a)2(stfe)-3.8(eding)]TJ
-12.9881 -1.1116 TD
.012 Tc
[(on)-386.5(th)5.1(e)-387.7(a)-1.8(f)5.2(f)-.6(ected)-386.5(b)-.6(r)5.2(e)-1.8(ast)-386.6(s)-.4(h)5.1(oul)5(d)-386.5(c)-1.8(o)5.1(n)-.6(ti)5(nu)5.1(e,)-383.1(even)-386.5(if)-386.5(a)-387.7(d)-.6(r)5.2(a)-1.8(i)5(n)-386.5(is)]TJ
0 -1.1174 TD
.0118 Tc
[(present)4.8(,)-354.5(w)4.1(it)4.8(h)-352.2(t)-.9(h)4.9(e)-353.3(pr)5(ov)4.9(iso)-346.4(t)-.9(h)4.9(a)-2(t)-352.3(t)4.8(he)-353.3(i)4.8(n)-.8(f)5(a)-2(n)4.9(t)-.9(s)-352(mo)4.9(uth)-346.4(does)-352(n)4.9(ot)]TJ
0 -1.1116 TD
.0131 Tc
[(co)6.2(me)-271.4(in)6.2(to)-270.2(d)6.2(i).4(re)5.1(ct)-270.4(c)5.1(ont)6.1(ac)5.1(t)-270.4(w)-.4(i)6.1(t).4(h)-270.2(p).5(u)6.2(rul)6.1(en)6.2(t)-270.4(dra)5.1(in)6.2(ag)6.2(e)-271.4(o).5(r)-270.2(i).4(n)6.2(f).5(e)5.1(c)-.7(te)5.1(d)]TJ
T*
.0122 Tc
[(tis)5.5(su)5.3(e.)-227.4(A)-231.7(c)-1.6(o)5.3(urs)5.5(e)-232(o)-.4(f)-230.8(a)4.2(nt)5.2(ib)5.3(io)5.3(tics)-230.6(s)-.2(h)5.3(o)-.4(u)5.3(l)-.5(d)-230.8(f)-.4(o)5.3(l)-.5(l)5.2(o)-.4(w)-231.7(d)5.3(rainage)-226.2(o)-.4(f)-230.8(t)-.5(h)5.3(e)]TJ
T*
.0125 Tc
[(ab)5.6(scess)5.8(.)-278.9(\(I)5.7(II\))]TJ
1.0137 -1.1174 TD
0 Tc
[(Photographs)-295.3(of)-290.2(breast)-296.8(abscesses)-296(and)-292.4(percutaneous)-294.2(aspira-)]TJ
-1.0137 -1.1116 TD
[(tion)-281.1(can)-282.1(be)-285.6(found)-276.2(in)-284.6(a)-278.7(2013)-280.9(review)-280.6(by)-284.4(Kataria)-283(et)-280(al.)]TJ
7.3823 0 0 6.5614 265.9464 285.6755 Tm
(34)Tj
/F2 1 Tf
8.9663 0 0 8.9663 59.7543 259.37 Tm
(Candida)Tj
/F11 1 Tf
4.034 0 TD
(infection)Tj
/F4 1 Tf
9.843 0 0 9.843 69.7323 242.929 Tm
.013 Tc
[(Ca)6.1(nd)6.1(id)6.1(a)]TJ
/F8 1 Tf
4.1124 0 TD
[(inf)6.3(e)-.7(c)5.1(t).4(i)6.1(o).5(n)-592.8(h).5(a)5.1(s)-592.6(be)5.1(en)-592.8(a)5.1(sso)6.2(ci)6.1(at)6.1(ed)-592.8(w)5.4(ith)-592.8(b)6.2(u).5(r)6.3(n).5(in)6.2(g)]TJ
-5.1261 -1.1116 TD
.0121 Tc
[(nip)5.2(p)-.5(l)5.1(e)-272.4(p)5.2(a)-1.7(in)-265.5(or)-271.2(r)5.3(a)-1.7(d)5.2(i)-.6(atin)5.2(g)-271.2(b)5.2(reast)-265.6(p)-.5(ai)5.1(n)-271.2(s)5.4(ympto)5.2(m)-1.7(s)5.4(.)]TJ
7.3823 0 0 6.5614 248.4283 236.3527 Tm
.0145 Tc
(18)Tj
9.843 0 0 9.843 258.6897 231.9873 Tm
.0131 Tc
[(Dia)5.1(g).5(n)6.2(o).5(s)6.4(i).4(s)]TJ
-20.2108 -1.1116 TD
.0124 Tc
[(is)-316.8(d)5.5(i)-.3(f)5.7(cu)5.5(lt)5.4(,)-319.3(a)4.4(s)-316.8(t)-.3(h)5.5(e)-318.2(ni)5.4(pp)5.5(les)-311(a)-1.4(nd)-311.2(breas)5.7(ts)-316.8(may)-311.2(l)-.3(oo)5.5(k)-317(n)-.2(o)5.5(r)-.2(mal)-311.4(o)-.2(n)]TJ
0 -1.1174 TD
.0131 Tc
[(ex)6.2(am)5(ina)5.1(t).4(i)6.1(o).5(n)6.2(,)-382(a)5.1(n).5(d)-379.7(m)5(il)6.1(k)-379.7(c)-.7(u)6.2(l).4(t)6.1(ure)-380.8(m)5(a)5.1(y)-379.7(not)-374(be)-380.8(r)6.3(e)-.7(li)6.1(ab)6.2(le)5.1(.)-382(C)5.2(ar)6.3(e-)]TJ
0 -1.1116 TD
.0073 Tc
[(f)-5.3(u)-5.3(l)-310.7(ev)-5.3(al)-5.4(ua)-6.5(t)-5.4(i).3(o)-5.3(n)-310.6(fo)-5.3(r)-310.5(o)-5.3(th)-5.3(er)-316.3(et)-5.4(io)-5.3(lo)-5.3(g)-5.3(i).3(e)-6.5(s)-310.4(of)-316.3(br)-5.3(ea)-6.5(s)-5.1(t)-310.7(pa)-6.5(in)-310.6(s)-5.1(h)-5.3(ou)-5.3(ld)-316.3(be)]TJ
T*
.0114 Tc
[(und)4.5(er)4.6(taken)-485(w)-2.1(i)4.4(t)-1.3(h)-479.3(p)-1.2(arti)4.4(cu)4.5(lar)-485(a)-2.4(t)4.4(t)-1.3(ent)4.4(i)-1.3(on)-479.3(to)-485(p)4.5(r)-1.2(o)4.5(p)-1.2(er)-485(latch)-485(a)3.4(nd)]TJ
T*
.0119 Tc
[(rul)4.9(in)5(g)-380.9(o)5(ut)-375.2(Rayn)5(aud)5()-.7(s)5.2(/)-.8(v)5(a)-1.9(so)5(sp)5(asm)-376.3(a)3.9(nd)-375.1(local)-375.2(n)-.7(i)4.9(p)-.7(p)5(l)-.8(e)-376.3(t)-.8(r)5.1(a)-1.9(uma.)]TJ
0 -1.1174 TD
.0126 Tc
[(Wh)5.7(en)-449.3(wou)5.7(n)0(d)-449.3(c)4.6(ult)5.6(u)0(r)5.8(e)-1.2(s)-449.1(a)4.6(re)-450.4(ob)5.7(tain)5.7(ed)-449.3(f)5.8(rom)-444.7(nip)5.7(p)0(l)5.6(e)-450.4(s)5.9(sur)5.8(e)-1.2(s)5.9(,)]TJ
0 -1.1116 TD
.0074 Tc
[(t)-5.3(h)-5.2(ey)-281.7(m)-6.4(o).5(s)-5(t)-281.8(c)-6.4(o).5(mm)-6.4(on)-5.2(l)-5.3(y)-281.7(gr)-5.2(ow)]TJ
/F4 1 Tf
11.3466 0 TD
.0069 Tc
[(S.)-284.5(au)-5.7(r)-5.5(e)-1.1(u)-5.7(s)]TJ
/F8 1 Tf
3.8244 0 TD
0 Tc
(.)Tj
7.3823 0 0 6.5614 211.6913 159.6472 Tm
.0145 Tc
[(353)14.5(7)]TJ
9.843 0 0 9.843 233.4047 155.2818 Tm
.0126 Tc
[(\(I)5.8(\))]TJ
-16.6283 -1.1116 TD
0 Tc
[(A)-652.8(recent)-649.5(investigation)-656.4(of)-647.3(women)-653.9(with)-650.6(these)-652.9(typical)]TJ
-1.0137 -1.1174 TD
[(symptoms,)-584.7(using)-581.4(breastmilk)-579.2(cultures)-587.1(after)-578.1(cleansing)-583.7(the)]TJ
0 -1.1116 TD
[(nipples,)-311.9(found)-310.7(that)-311.1(none)-310.8(of)-307.4(the)-309.9(35)-313.2(cultures)-310.7(from)-310.8(the)-309.9(control)]TJ
T*
[(group)-195.5(of)-192.2(women)-198.8(grew)]TJ
/F4 1 Tf
8.8872 0 TD
(Candida)Tj
/F8 1 Tf
3.4501 0 TD
[(,)-193.5(whereas)-196.2(only)-194.6(one)-194.5(of)-192.2(29)-192.3(in)-192.4(the)]TJ
-12.3373 -1.1174 TD
[(symptomatic)-293.6(group)-287.7(grew)-288.6(the)-292.6(organism.)]TJ
7.3823 0 0 6.5614 216.0566 104.8819 Tm
(38)Tj
9.843 0 0 9.843 226.3181 100.4598 Tm
[(\(I\))-285.4(There)-291.2(was)-293.1(also)]TJ
-16.922 -1.1116 TD
[(no)-249.9(signicant)-255.3(difference)-257.6(in)-250(the)-246.5(measurement)-255.3(of)-249.8(a)-255.7(by-product)]TJ
T*
(of)Tj
/F4 1 Tf
1.0655 0 TD
(Candida)Tj
/F8 1 Tf
3.6805 0 TD
[(growth)-232.2([\(1,3\))]TJ
/F12 1 Tf
5.3104 0 TD
(b)Tj
/F8 1 Tf
.5529 0 TD
(-)Tj
/F7 1 Tf
.3341 0 TD
(d)Tj
/F8 1 Tf
.5529 0 TD
[(-glucan])-235.8(between)-231.1(groups.)]TJ
7.3823 0 0 6.5614 272.5228 82.9417 Tm
(38)Tj
9.843 0 0 9.843 282.1606 78.5763 Tm
(Yet,)Tj
-22.5953 -1.1174 TD
[(evidence)-192.1(is)-180.7(conicting)-186.4(as)-187.5(another)-188.7(recent)-183(study)-189.8(on)-180.7(milk)-184.4(culture)]TJ
0 -1.1116 TD
[(found)-385.6(that)-386(30%)-384.5(of)-382.3(symptomatic)-391.5(mothers)-384.4(were)-387.7(positive)-384.6(for)]TJ
/F4 1 Tf
25.5097 67.9184 TD
(Candida)Tj
/F8 1 Tf
3.4501 0 TD
[(,)-274.1(whereas)-282.6(8%)-274(of)-278.6(women)-279.5(in)-278.8(the)-275.3(asymptoma)-8.9(tic)-275.4(group)]TJ
-3.4501 -1.1174 TD
[(grew)-282.9(the)-281.1(organism.)]TJ
7.3823 0 0 6.5614 387.3259 718.5825 Tm
(39)Tj
9.843 0 0 9.843 397.4739 714.1605 Tm
(\(I\))Tj
-7.7871 -1.1116 TD
[(Women)-315.4(with)-316.6(burning)-313.1(nipple)-319.1(and)-309.7(breast)-319.9(pain)-316.7(may)-316.7(also)-316.5(be)]TJ
-1.0137 -1.1116 TD
[(more)-340.8(likely)-342.2(to)-342.1(test)-339.7(positive)-344.2(for)]TJ
/F4 1 Tf
12.919 0 TD
(Candida)Tj
/F8 1 Tf
3.7841 0 TD
[(on)-342(nipple)-342.1(swab)-346.1(by)]TJ
-16.7031 -1.1116 TD
[(polymerase)-286.4(chain)-290.2(reaction.)]TJ
7.3823 0 0 6.5614 417.77 685.7006 Tm
(40)Tj
9.843 0 0 9.843 427.9747 681.3352 Tm
[(Using)-288.5(molecular)-291.3(techniques)-291(as)]TJ
-11.8995 -1.1174 TD
[(well)-288.9(as)-285.4(standard)-293.3(culture,)-290.2(a)-290.2(large)-290.2(cohort)-284.3(study)-293.4(of)-284.4(women)-291(fol-)]TJ
0 -1.1116 TD
[(lowed)-301.4(up)-295.9(for)-302.7(8)-300.6(weeks)-302.3(postpartum)-301.4(found)-299.2(that)-305.3(burning)-295.8(nipple)]TJ
T*
[(pain)-322.5(with)-328.1(breast)-331.4(pain)-322.5(was)-327.7(associated)-332.3(with)]TJ
/F4 1 Tf
17.3713 0 TD
(Candida)Tj
/F8 1 Tf
3.7726 0 TD
(species,)Tj
-21.1439 -1.1174 TD
[(but)-279.9(not)-279.9(with)]TJ
/F4 1 Tf
5.1837 0 TD
[(S.)-281(aureus)]TJ
/F8 1 Tf
3.7496 0 TD
(.)Tj
7.3823 0 0 6.5614 401.2156 641.877 Tm
(41)Tj
9.843 0 0 9.843 411.3636 637.455 Tm
(\(II-2\))Tj
-9.1982 -1.1116 TD
[(Further)-268(research)-278.1(in)-267.3(this)-275.2(area)-272.8(is)-272.8(required.)-273.8(Until)-271.7(then,)-268.3(a)-273(trial)]TJ
-1.0137 -1.1116 TD
[(of)-324.7(antifungal)-330.5(medications,)-325.7(either)-331.7(with)-322.3(or)-330.5(without)-325.8(culture,)-324.7(is)]TJ
0 -1.1174 TD
[(the)-281.1(current)-280.8(expert)-285.5(consensus)-282.4(recommendation.)-285.4(\(III\))]TJ
/F5 1 Tf
8.9663 0 0 8.9663 310.8472 580.7054 Tm
[(Prevention)-331.6(\(III\))]TJ
6.7246 0 0 5.9768 373.6629 584.6738 Tm
(8)Tj
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 564.2644 Tm
[(Effective)-335.8(management)-328.6(of)-336.7(breast)-334.6(fullness)-332.2(and)]TJ
0 -1.2266 TD
(engorgement)Tj
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 538.129 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 536.8251 Tm
[(Mothers)-407.1(should)-404(be)-406.5(helped)-406.5(to)-399.7(improve)-407.6(infants)-407.4(attach-)]TJ
0 -1.1116 TD
[(ment)-335.2(to)-336.4(the)-332.9(breast.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 516.2455 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 514.9416 Tm
[(Feeds)-335.8(should)-334.9(not)-337.5(be)-331.7(restricted.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 505.2471 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 503.9999 Tm
[(Mothers)-499.3(should)-496.1(be)-492.9(taught)-497.6(to)-491.9(hand-express)-500.1(when)-496(the)]TJ
0 -1.1174 TD
[(breasts)-309.2(are)-310.9(too)-302.9(full)-304.1(for)-308.5(the)-304.1(infant)-307.5(to)-307.6(attach)-304.1(or)-307.4(the)-304.1(infant)]TJ
0 -1.1116 TD
[(does)-460.4(not)-452.7(relieve)-460.7(breast)-452.3(fullness.)-456.7(A)-457(breast)-458.1(pump)-454.9(may)]TJ
T*
[(also)-437.5(be)-435.3(used,)-435(if)-434.3(available,)-438.8(for)-435.2(these)-434(purposes,)-439.2(but)-435.4(all)]TJ
0 -1.1174 TD
[(mothers)-269.2(should)-265.7(be)-262.5(able)-266(to)-267.3(manually)-266.1(express)-263(as)-268.1(the)-263.8(need)]TJ
0 -1.1116 TD
[(for)-337.3(its)-331.7(use)-338.3(may)-334(arise)-336(unexpectedly.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 425.2534 Tm
[(Prompt)-330.2(attention)-339.5(to)-330.4(any)-337.1(signs)-333.6(of)-330.4(milk)-336.5(stasis)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 410.1164 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 408.8125 Tm
[(Mothers)-505(should)-501.9(be)-498.7(taught)-503.4(to)-497.7(check)-504.3(their)-502.2(breasts)-505.1(for)]TJ
T*
[(lumps,)-338.4(pain,)-331.7(or)-336.2(redness.)]TJ
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 388.233 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 386.929 Tm
[(If)-261.3(the)-258(mother)-262.5(notices)-257.8(any)-263.7(signs)-258.7(of)-255.6(milk)-259.3(stasis,)-264.3(she)-257.7(needs)]TJ
0 -1.1174 TD
[(to)-382.5(rest,)-377.5(increase)-382(the)-379(frequency)-382(of)-376.5(breastfeeding,)-385.3(apply)]TJ
0 -1.1116 TD
[(heat)-410(to)-399.7(the)-402(breast)-406.3(prior)-403(to)-405.5(feedings,)-406.1(and)-401.9(massage)-409.5(any)]TJ
T*
[(lumpy)-340.9(areas)-337.1(as)-337.2(described)-341.6(in)-336.4(the)-332.9(section)-344.2(Effective)-337.3(milk)]TJ
0 -1.1174 TD
(removal.)Tj
/F10 1 Tf
7.9702 0 0 7.9702 320.8251 333.4109 Tm
()Tj
/F8 1 Tf
9.843 0 0 9.843 329.6692 332.107 Tm
[(Mothers)-585.7(should)-582.5(contact)-581.7(their)-582.9(healthcare)-581.5(provider)-586(if)]TJ
0 -1.1116 TD
[(symptoms)-339.3(are)-333.9(not)-331.7(improving)-339.7(within)-330.4(24)-336.3(hours.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 297.0708 Tm
[(Prompt)-279.6(attention)-282.6(to)-279.8(other)-278.1(difculties)-288(with)-279.6(breastfeeding)]TJ
/F8 1 Tf
9.843 0 0 9.843 320.8251 280.6299 Tm
[(Skilled)-181.9(help)-190(is)-186.4(needed)-182.9(for)-187.5(mothers)-188.6(with)-184.1(damaged)-191(nipples)-187.5(or)]TJ
-1.0137 -1.1174 TD
[(an)-268.3(unsettled)-277.4(discontent)-272.7(infant)-272.9(or)-272.9(those)-271.5(who)-269.1(believe)-276.4(that)-270.8(they)]TJ
0 -1.1116 TD
[(have)-283.2(an)-279.8(insufcient)-285.2(milk)-276.6(supply.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 234.3684 Tm
(Rest)Tj
/F8 1 Tf
9.843 0 0 9.843 320.8251 217.9275 Tm
[(As)-515.5(fatigue)-517.1(is)-520.5(often)-513.6(a)-520.6(precursor)-518.8(to)-514.9(mastitis,)-521.6(healthcare)]TJ
-1.0137 -1.1116 TD
[(providers)-298.9(should)-300.3(encourage)-302.5(breastfeeding)-301.2(mothers)-303.8(to)-296.1(obtain)]TJ
T*
[(adequate)-244(rest.)-245(It)-244.2(may)-247.6(also)-241.6(be)-245.3(helpful)-245.3(for)-239.4(healthcare)-253.2(providers)]TJ
0 -1.1174 TD
[(to)-353.7(remind)-360.4(family)-354.8(members)-357.9(that)-357.2(breastfeeding)-364.6(mothers)-355.6(may)]TJ
0 -1.1116 TD
[(need)-398.4(more)-392.7(help)-397.4(and)-396.1(encou)-7.8(rage)-392.6(mothers)-401.7(to)-394(ask)-395.9(for)-400.7(help)-397.4(as)]TJ
T*
(necessary.)Tj
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 138.8409 Tm
[(Good)-332.4(hygiene)]TJ
/F8 1 Tf
9.843 0 0 9.843 320.8251 122.3999 Tm
(Because)Tj
/F4 1 Tf
3.5249 0 TD
[(S.)-183.1(aureus)]TJ
/F8 1 Tf
3.836 0 TD
[(is)-186.4(a)-186.6(common)-188.8(commensal)-188.6(organism)-183.9(often)]TJ
-8.3746 -1.1116 TD
[(present)-200(in)-198.2(hospitals)-201.1(and)-194.5(communiti)-8.2(es,)-196.7(the)-200.4(importance)-200.3(of)-198(good)]TJ
0 -1.1174 TD
[(ha)19.7(nd)-203.8(hy)20.8(gi)20.7(en)19.7(e)-209.6(s)0(h)15.3(o)0(u)20.8(l)0(d)-203.9(n)0(o)20.8(t)-208.6(be)-205(ov)20.8(er)19.7(lo)20.7(ok)15.1(ed)19.7(.)]TJ
7.3823 0 0 6.5614 463.9747 104.8819 Tm
[(14)24.7(,4)20.4(2)]TJ
9.843 0 0 9.843 482.3432 100.4598 Tm
[(It)-198.1(is)-203.7(im)19.5(po)20.8(rt)15(an)19.7(t)-208.6(f)0(o)20.9(r)]TJ
-17.4231 -1.1116 TD
[(ho)20.8(sp)21(it)20.6(al)-205.1(st)20.9(af)19.7(f,)-200.3(ne)19.7(w)-209.3(m)0(o)19.6(t)0(h)15(e)0(r)19.7(s)0(,)-200.2(a)0(n)19.7(d)-208.4(th)20.7(ei)19.5(r)-214.2(f)0(a)19.7(m)0(i)19.5(l)0(i)20.6(e)0(s)-199(t)0(o)-203.9(p)0(r)20.9(a)0(c)18.5(t)0(i)20.6(c)0(e)-200.3(g)0(o)20.8(o)0(d)]TJ
T*
[(ha)19.7(nd)-192.3(hy)20.8(gi)20.7(en)19.7(e.)-195.8(Br)19.8(ea)18.5(st)-192.2(pu)15.1(mp)-187.7(eq)13.9(ui)20.7(pm)19.6(en)19.7(t)-202.8(m)0(a)18.4(y)-202.7(al)19.5(so)-192.1(be)-193.4(a)-203.8(s)0(o)21(u)0(r)20.9(c)0(e)-194.6(o)0(f)]TJ
T*
[(co)19.7(nt)20.7(am)18.4(in)20.7(at)19.5(io)15(n)-179.6(a)0(n)19.7(d)-179.6(sh)21(ou)20.8(ld)-169.4(be)-170.4(wa)18.8(sh)15.3(ed)-170.4(th)20.7(or)20.9(ou)20.8(gh)15.1(ly)-169.4(wi)19.8(th)-169.4(so)21(ap)-170.4(an)19.7(d)]TJ
0 -1.1174 TD
[(ho)20.8(t)-271.9(w)0(a)18.8(t)0(e)19.5(r)-271.8(af)19.7(te)19.6(r)-271.8(u)0(s)21(e)0(.)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(ABM)-336(PROTOCOL)]TJ
53.0113 0 TD
(241)Tj
ET
endstream
endobj
46 0 obj
<>stream
EFIKJM+AdvPSMP10 qh
AdvPSMP10 C ߵ}Ebo=g{}`hkVX/Y+3mig Ev]yhD].n=K:Ufypo]]l1i
endstream
endobj
47 0 obj
<>
endobj
48 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 50 0 R/MediaBox[0 0 612 792]/Annots[51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R 112 0 R 113 0 R 114 0 R 115 0 R 116 0 R 117 0 R 118 0 R]/Rotate 0>>
endobj
119 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
49 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[(Recommendations)-337.4(for)-337.3(Future)-334(Research)]TJ
/F8 1 Tf
9.843 0 0 9.843 72 709.3416 Tm
[(There)-446.7(are)-443.3(several)-448.8(aspects)-448.7(of)-445.7(prevention,)-449(diagnosis,)-446.4(and)]TJ
-1.0137 -1.1116 TD
[(treatment)-256.9(of)-249.8(mastitis)-253.2(that)-247.7(require)-252(research.)-258.5(First,)-250.7(a)-249.9(consensus)]TJ
0 -1.1174 TD
[(on)-284.4(a)-284.5(denition)-287.8(of)-284.4(mastitis)-287.8(is)-284.4(vital.)]TJ
7.3823 0 0 6.5614 196.4976 691.8234 Tm
(43)Tj
9.843 0 0 9.843 206.7023 687.4014 Tm
[(We)-282.1(need)-289(to)-284.6(know)-281.7(when)]TJ
-14.6988 -1.1116 TD
[(antibiotics)-320.2(are)-310.9(needed,)-318.8(which)-318.7(are)-310.9(the)-315.6(most)-316.6(appropriate)-315.3(anti-)]TJ
T*
[(biotics,)-381.1(and)-384.6(the)-379(optimal)-384.9(duration)-384.6(of)-376.5(treatment.)-387(The)-385.8(role)-380(of)]TJ
0 -1.1174 TD
[(probiotics)-455.8(in)-445.8(prevention)-457.1(and)-448(treatment)-458.5(needs)-451.1(to)-451.6(be)-452.6(deter-)]TJ
0 -1.1116 TD
[(mined.)-201.5(Finally,)-202.6(the)-200.4(role)-195.7(of)-203.8(massage)-202.1(to)-198.2(prevent)-200.2(and)-200.3(treat)-203.9(breast)]TJ
T*
[(engorgement)-287.7(and)-280.9(infection)-283.3(needs)-278.3(to)-284.5(be)-279.8(claried.)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 62.022 606.7274 Tm
(Acknowledgments)Tj
/F8 1 Tf
9.843 0 0 9.843 72 590.2864 Tm
[(This)-293.5(work)-299(was)-298.9(supported)-293.2(in)-296.1(part)-299.4(by)-295.9(a)-296(grant)-294.8(from)-293.6(the)-298.3(Ma-)]TJ
-1.0137 -1.1116 TD
[(ternal)-314.4(and)-309.7(Child)-312.1(Health)-309.6(Bureau,)-312.9(U.S.)-315(Department)-310.6(of)-313.2(Health)]TJ
0 -1.1174 TD
[(and)-280.9(Human)-285.2(Services.)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 62.022 542.4377 Tm
(References)Tj
/F8 1 Tf
9.2951 0 0 9.2951 66.6708 526.3936 Tm
[(1.)-500.4(Waldenstro)]TJ
5.4588 .0244 TD
()Tj
.4147 -.0244 TD
[(m)-469.3(U)0(,)-465.3(Aarts)-470.9(C.)-468.5(Duration)-465.6(of)-466.2(breastfeeding)-472.7(and)]TJ
-4.6232 -1.1223 TD
[(breastfeeding)-338.5(problems)-341.3(in)-335.2(relation)-339.5(to)-335.2(length)-333.3(of)-338.1(postpartum)]TJ
0 -1.1284 TD
[(stay:)-484.7(A)-483.5(longitudinal)-484.9(cohort)-488.7(study)-481.1(of)-484.4(a)-486.2(national)-489.7(Swedish)]TJ
0 -1.1223 TD
(sample.)Tj
/F4 1 Tf
3.4278 0 TD
[(Acta)-335.5(Paediatr)]TJ
/F8 1 Tf
6.0199 0 TD
(2004;93:669676.)Tj
-10.6981 -1.1284 TD
[(2.)-500.4(Foxman)-257.6(B,)-255.1(DArcy)-256.8(H,)-258(Gillespie)-258.2(B,)-255.1(et)-260.1(al.)-254.1(Lactation)-258.1(mastitis:)]TJ
1.2503 -1.1223 TD
[(Occurrence)-443.5(and)-437.7(medical)-439(management)-443.8(among)-437.6(946)-433.5(breast-)]TJ
0 -1.1284 TD
[(feeding)-273.4(women)-274.4(in)-268.1(the)-278.5(United)-267.8(States.)]TJ
/F4 1 Tf
14.9736 0 TD
[(Am)-272.1(J)-272.7(Epidemiol)]TJ
/F8 1 Tf
6.7214 0 TD
(2002;)Tj
-21.695 -1.1284 TD
(155:103114.)Tj
-1.2503 -1.1223 TD
.0184 Tc
[(3)18.4(.)-482(Ami)-5.6(r)-484.2(LH,)-481.8(F)-2.9(ors)-5.2(t).5(e)-4.2(r)-484.2(DA,)-487.9(Luml)-5.6(ey)-488(J,)-487.9(et)-487.4(al)-5.6(.)-481.8(A)-483.4(d)-6.1(e)1.9(s)-5.2(c)-4.2(ript)-5.6(ive)]TJ
1.2503 -1.1284 TD
.0192 Tc
[(st)-4.8(udy)-560.4(o)-5.3(f)-556.6(m)-4.9(a)2.7(s)-4.4(t)1.3(i)-4.8(tis)-559.5(i)-4.8(n)-560.4(Aus)-4.4(t)1.3(ralian)-560.4(b).8(reast)-4.8(f)-1.6(eedi)-4.8(ng)-560.4(wom)-4.9(e)2.7(n:)]TJ
0 -1.1223 TD
[(Incid)-5.3(e)2.7(nce)-430.4(a)2.7(n)-5.3(d)-426.2(determin)-5.3(an)-5.3(ts.)]TJ
/F4 1 Tf
12.5705 0 TD
.018 Tc
[(BMC)-432.2(P)-2.3(ubl)-6(ic)-431.6(Hea)-6.5(lth)]TJ
/F8 1 Tf
9.0391 0 TD
.0184 Tc
[(2)-6.1(007;)]TJ
-21.6096 -1.1284 TD
[(7:)-5.6(62.)]TJ
-1.2503 -1.1223 TD
0 Tc
[(4.)-500.4(Appendix)-463.8(A)-459.2(Task)-463.2(Force)-459.6(Ratings.)-465.5(Guide)-463.4(to)-457.2(Clinical)-463.4(Pre-)]TJ
1.2503 -1.1284 TD
[(ventive)-441.3(Services:)-450.2(Report)-438.6(of)-441.7(the)-443.2(U.S.)-444.1(Preventive)-445.1(Services)]TJ
0 -1.1223 TD
[(Task)-695(Force,)-697.5(2nd)-695.7(edition.)-692.8(www.ncbi.nlm.nih.gov/books/)]TJ
0 -1.1284 TD
[(NBK15430)-332.4(\(accessed)-340(May)-339.4(7,)-329.6(2014\).)]TJ
-1.2503 -1.1223 TD
[(5.)-500.4(Lawrence)-414.1(RA.)-409.3(The)-409.1(puerperium,)-410(breastfeeding,)-411.8(and)-407.2(breast)]TJ
1.2503 -1.1284 TD
(milk.)Tj
/F4 1 Tf
2.4275 0 TD
[(Curr)-332.9(Opin)-337(Obstet)-334(Gynecol)]TJ
/F8 1 Tf
11.2287 0 TD
(1990;2:2330.)Tj
-14.9065 -1.1223 TD
[(6.)-500.4(Inch)-312.1(S,)-314.2(Renfrew)-319.3(MJ.)-315.9(Common)-309.8(breastfeeding)-320.2(problems.)-316.9(In:)]TJ
1.2503 -1.1284 TD
[(Chalmers)-490.5(I,)-484.4(Enkin)-483.9(M,)-487.4(Keirse)-487.5(M,)-487.4(eds.)]TJ
/F4 1 Tf
16.6875 0 TD
[(Effective)-493.5(Care)-484.4(in)]TJ
-16.6875 -1.1223 TD
[(Pregnancy)-448(and)-451.8(Childbirth)]TJ
/F8 1 Tf
10.9176 0 TD
[(.)-445.3(Oxford)-446.2(University)-452.2(Press,)-447.6(Ox-)]TJ
-10.9176 -1.1284 TD
[(ford,)-334.7(United)-334.9(Kingdom,)-337.1(1989:13751389.)]TJ
-1.2503 -1.1223 TD
[(7.)-500.4(World)-525.3(Health)-522(Organization.)]TJ
/F4 1 Tf
13.5464 0 TD
[(Mastitis:)-520.5(Causes)-526.5(and)-518.9(Man-)]TJ
-12.2961 -1.1284 TD
(agement)Tj
/F8 1 Tf
3.3973 0 TD
[(.)-969.8(Publication)-980.4(number)-976.7(WHO/FCH/CAH/00.13.)]TJ
-3.3973 -1.1223 TD
[(World)-336.2(Health)-333(Organization,)-339.9(Geneva,)-338.4(2000.)]TJ
-1.2503 -1.1284 TD
-.0183 Tc
[(8)-18.3(.)-518.7(Walker)-283(M.)-280.6(Masti)6.5(tis)-279.8(in)-280.7(lact)6.5(at)6.5(ing)-280.7(w)-1.7(o)6(m).3(en.)]TJ
/F4 1 Tf
17.0596 0 TD
-.0188 Tc
[(Lactatio)5.5(n)-281.2(C).7(onsu)5.5(ltan)5.5(t)]TJ
-15.8092 -1.1223 TD
-.0196 Tc
[(Series)-305.5(Two)]TJ
/F8 1 Tf
4.2939 0 TD
[(.)-306.2(S)1.9(chaumburg,)-306.2(IL:)-305.7(L)-3.2(a)-304.4(L)-3.2(eche)-310.5(L)2.9(eague)-304.4(Interna)-5.5(t)5.3(ional,)]TJ
-4.2939 -1.1284 TD
-.0182 Tc
[(20)6.1(04.)]TJ
-1.2503 -1.1223 TD
0 Tc
[(9.)-500.4(OHara)-254.9(M-A.)-253.7(Bleb)-253(histology)-248.8(reveals)-258.5(inammatory)-251.1(inltrate)]TJ
1.2503 -1.1284 TD
[(that)-333(regresses)-333.1(with)-330.4(topical)-331(steroids;)-327.6(a)-333.7(case)-329.5(series)-332.5([platform)]TJ
0 -1.1223 TD
(abstract].)Tj
/F4 1 Tf
4.0438 0 TD
[(Breastfeed)-336.3(Med)]TJ
/F8 1 Tf
6.7397 0 TD
[(2012;7\(Suppl)-329.1(1\):S-2.)]TJ
-12.5339 -1.1284 TD
[(10.)-500.5(Matheson)-452.6(I,)-447.8(Aursnes)-452.6(I,)-453.9(Horgen)-448.1(M,)-450.8(et)-455.3(al.)-449.2(Bacteriological)]TJ
1.7505 -1.1223 TD
[(ndings)-374.5(and)-376.7(clinical)-383.5(symptoms)-376.1(in)-371.8(relation)-382.2(to)-377.9(clinical)-377.4(out-)]TJ
0 -1.1284 TD
[(come)-514.8(in)-518.1(puerperal)-518.1(mastitis.)]TJ
/F4 1 Tf
12.1802 0 TD
[(Acta)-518.4(Obstet)-517(Gynecol)-514.8(Scand)]TJ
/F8 1 Tf
-12.1802 -1.1223 TD
(1988;67:723726.)Tj
-1.7505 -1.1284 TD
[(11.)-500.5(Thomsen)-384(AC,)-391(Espersen)-384.1(T,)-386.4(Maigaard)-392.9(S.)-381.3(Course)-389.4(and)-382.8(treat-)]TJ
1.7505 -1.1223 TD
[(ment)-571(of)-569.8(milk)-572.3(stasis,)-574.7(noninfectious)-571.1(inammation)-577.6(of)-569.8(the)]TJ
0 -1.1284 TD
[(breast,)-510.4(and)-504.8(infectious)-503.6(mastitis)-507.1(in)-505.9(nursing)-508.1(women.)]TJ
/F4 1 Tf
21.6889 0 TD
[(Am)-503.9(J)]TJ
-21.6889 -1.1223 TD
[(Obstet)-334(Gynecol)]TJ
/F8 1 Tf
6.6238 0 TD
(1984;149:492495.)Tj
-8.3742 -1.1284 TD
[(12.)-500.5(Bolman)-271.1(M,)-267.8(Saju)-275.5(L,)-264.4(Oganesyan)-276.9(K,)-270.2(et)-272.3(al.)-266.3(Recapturing)-276.3(the)-266.3(art)]TJ
1.7505 -1.1223 TD
[(of)-319.8(therapeutic)-317.9(breast)-321.2(massage)-322.5(during)-319.8(breastfeeding.)]TJ
/F4 1 Tf
21.268 0 TD
[(J)-321.5(Hum)]TJ
-21.268 -1.1284 TD
(Lact)Tj
/F8 1 Tf
2.1164 0 TD
(2013;29:328331.)Tj
-3.8669 -1.1284 TD
[(13.)-500.5(Sachs)-303.9(HC;)-299(Committee)-304.7(on)-299.1(Drugs.)-296.6(The)-305.4(transfer)-301.7(of)-295.4(drugs)-301(and)]TJ
1.7505 -1.1223 TD
[(therapeutics)-274.4(into)-273.9(human)-272.9(breast)-272.4(milk:)-273(An)-276.3(update)-271(on)-274.8(selected)]TJ
0 -1.1284 TD
(topics.)Tj
/F4 1 Tf
2.9764 0 TD
(Pediatrics)Tj
/F8 1 Tf
4.4585 0 TD
(2013;132:e796e809.)Tj
17.822 70.9036 TD
[(14.)-500.5(Amir)-332.8(LH,)-333.2(Garland)-336(SM,)-325.8(Lumley)-335.3(J.)-328.7(A)-331.1(case-control)-338.3(study)-328.6(of)]TJ
1.7505 -1.1223 TD
[(mastitis:)-488.4(Nasal)-485(carriage)-485.6(of)]TJ
/F4 1 Tf
11.6922 0 TD
[(Staphylococcus)-486.5(aureus)]TJ
/F8 1 Tf
9.4355 0 TD
(.)Tj
/F4 1 Tf
.7319 0 TD
(BMC)Tj
-21.8597 -1.1284 TD
[(Fam)-339.4(Pract)]TJ
/F8 1 Tf
4.733 0 TD
(2006;7:57.)Tj
-6.4835 -1.1223 TD
-.0195 Tc
[(1)-19.5(5)-19.5(.)-520(Kvi)5.3(s)-.5(t)-500.9(L)2.9(J,)-495.3(Larsso)4.8(n)-495.4(B)0(W)-5.7(,)-495.3(Hall-Lord)-495.4(ML,)-495.3(e).6(t)-500.9(a).6(l.)-495.3(The)-493.5(r)-3.7(o)4.8(l)-.8(e)-499.6(o)4.8(f)]TJ
1.7505 -1.1283 TD
-.0183 Tc
[(bacteria)-291(in)-286.8(lact)6.5(at)6.5(ional)-292.3(m).3(ast)6.5(itis)-292(and)-292.9(s)6.8(ome)-291(c)1.8(onsi)6.5(d)-.1(eratio)6(ns)-292(of)-289.1(the)]TJ
0 -1.1223 TD
-.019 Tc
[(use)-334.4(o)-.8(f)-332.5(a)1.1(n)5.3(tibio)5.3(tic)-334.4(treatment.)]TJ
/F4 1 Tf
10.8566 0 TD
-.02 Tc
[(Int)-336.7(B)2.4(reastfe)-6(e).1(d)-331.2(J)]TJ
/F8 1 Tf
6.575 0 TD
-.0183 Tc
[(20)6(08;)6.5(3:6.)]TJ
-19.1821 -1.1284 TD
0 Tc
[(16.)-500.5(Antibiotic)-583.8(Expert)-582(Group.)]TJ
/F4 1 Tf
13.0402 0 TD
[(Therapeutic)-582.3(Guidelines:)-578.5(Anti-)]TJ
-11.2897 -1.1223 TD
(biotic)Tj
/F8 1 Tf
2.2933 0 TD
[(.)-335.5(Therapeutic)-338.6(Guidelines)-332.1(Ltd.,)-337.4(Melbourne,)-334.1(2010.)]TJ
-4.0438 -1.1284 TD
[(17.)-500.5(Olsson)-366.1(R,)-358.8(Wiholm)-357.4(BE,)-360.8(Sand)-361.4(C,)-358.8(et)-357.7(al.)-363.8(Liver)-356.2(damage)-366.8(from)]TJ
1.7505 -1.1223 TD
[(ucloxacillin,)-252.5(cloxacillin)-255.3(and)-248.6(dicloxacillin.)]TJ
/F4 1 Tf
17.5231 0 TD
[(J)-248.3(Hepatol)]TJ
/F8 1 Tf
4.1719 0 TD
(1992;)Tj
-21.695 -1.1284 TD
(15:154161.)Tj
-1.7505 -1.1223 TD
[(18.)-500.5(Lawrence)-365.3(RA,)-354.4(Lawrence)-359.2(RM.)]TJ
/F4 1 Tf
14.5284 0 TD
[(Breastfeeding:)-356.9(A)-355.8(Guide)-359.7(for)]TJ
-12.7779 -1.1284 TD
[(the)-595.7(Medical)-596.3(Profession,)]TJ
/F8 1 Tf
10.8383 0 TD
(7)Tj
6.9712 0 0 6.196 434.7211 603.7794 Tm
(th)Tj
9.2951 0 0 9.2951 445.6629 599.6407 Tm
[(edition.)-595.2(Mosby,)-596.9(St.)-594.3(Louis,)]TJ
-12.5156 -1.1284 TD
(2011.)Tj
-1.7505 -1.1223 TD
[(19.)-500.5(Neifert)-746.4(MR.)-736.3(Clinical)-744(aspects)-743.2(of)-740.6(lactation:)-743.1(Promoting)]TJ
1.7505 -1.1284 TD
[(breastfeeding)-338.5(success.)]TJ
/F4 1 Tf
9.3257 0 TD
[(Clin)-333.6(Perinatol)]TJ
/F8 1 Tf
6.1846 0 TD
(1999;26:281306.)Tj
-17.2608 -1.1223 TD
[(20.)-500.5(Perez)-561.4(A,)-550.7(Orta)-557(L,)-557.1(Padilla)-553.4(E,)-557.1(etal.)-556.8(CA-MRSA)-554.9(puerperal)]TJ
1.7505 -1.1284 TD
[(mastitis)-342.4(and)-334(breast)-339.5(abscess:)-339.9(A)-337.2(potential)-336.8(problem)-335.9(emerging)]TJ
0 -1.1223 TD
[(in)-249.8(Europe)-241.1(with)-245(many)-248.3(unanswered)-248.9(questions.)]TJ
/F4 1 Tf
17.9683 0 TD
[(J)-242.2(Matern)-250.1(Fetal)]TJ
-17.9683 -1.1284 TD
[(Neonatal)-338.4(Med)]TJ
/F8 1 Tf
6.1297 0 TD
(2013;26:949951.)Tj
-7.8802 -1.1223 TD
[(21.)-500.5(Branch-Elliman)-292.2(W,)-279(Golen)-286.5(TH,)-284.4(Gold)-282.1(HS,)-279.3(et)-284.5(al.)-284.6(Risk)-284.5(factors)]TJ
1.7505 -1.1284 TD
(for)Tj
/F4 1 Tf
1.4943 0 TD
[(Staphylococcus)-334(aureus)]TJ
/F8 1 Tf
9.6124 0 TD
[(postpartum)-334.9(breast)-327.3(abscess.)]TJ
/F4 1 Tf
11.1433 0 TD
(Clin)Tj
-22.25 -1.1223 TD
[(Infect)-339.8(Dis)]TJ
/F8 1 Tf
4.3488 0 TD
(2012;54:7177.)Tj
-6.0992 -1.1284 TD
[(22.)-500.5(St)15.7(af)17.6(fo)21.8(rd)-679.6(I,)-685.6(He)18.3(rn)21.8(an)13.8(de)19.9(z)-693.6(J)12.9(,)-695.4(L)0(a)18(i)12.6(bl)-682.8(V,)-684.9(et)-687(a)14(l)0(.)-682.7(C)0(o)19.3(m)0(m)18.9(u)0(n)18(i)0(t)19.2(y)0(-)]TJ
1.7505 -1.1223 TD
[(ac)15.7(qu)18(i)12.6(r)0(e)17.6(d)-317.3(me)20.3(th)18.6(ic)14.4(i)12.6(l)0(l)19.2(i)12.6(n-)15.7(re)17.6(s)12.9(i)0(s)19.5(t)0(a)20.5(n)0(t)]TJ
/F4 1 Tf
11.8691 0 TD
[(St)18.6(ap)18(hy)19.9(l)12.6(o)0(c)19.9(o)0(c)13.8(c)14(us)-310.5(au)18(r)12.9(e)0(u)13.8(s)]TJ
/F8 1 Tf
9.4172 0 TD
[(am)20.3(on)18(g)]TJ
-21.2863 -1.1284 TD
[(pa)13.8(t)12.6(i)12.6(e)0(n)13.8(t)12.6(s)-560.4(w)0(i)23.1(t)0(h)-548.6(p)0(u)18(e)0(r)17.6(p)0(e)19.9(r)0(a)17.6(l)-554.6(ma)20.3(st)19.5(it)19.2(is)-547.7(re)17.6(qu)18(i)12.6(r)0(i)16.3(n)0(g)-543.1(h)0(o)18(s)0(p)18.9(i)0(t)19.2(a)0(l)20.5(i)0(z)14.4(a)14(ti)19.2(on)18(.)]TJ
/F4 1 Tf
0 -1.1223 TD
[(Ob)16.4(s)12.9(t)0(e)14.4(t)-322.8(Gy)18.3(ne)19.9(co)19.9(l)]TJ
/F8 1 Tf
6.4957 0 TD
-.0182 Tc
[(2)-18.2(0)-.2(0)-18.2(8)-.2(;)-5.6(1)-18.2(12)-18.2(:5)-18.2(3)5.9(3)-18.2(5)-18.2(37)-18.2(.)]TJ
-8.2462 -1.1284 TD
0 Tc
[(23.)-500.5(Berens)-375.4(P,)-369.1(Swaim)-368.2(L,)-368.1(Peterson)-367.1(B.)-370.9(Incidence)-373.6(of)-368.6(methicillin-)]TJ
1.7505 -1.1223 TD
(resistant)Tj
/F4 1 Tf
3.7937 0 TD
[(Staphylococcus)-456(aureus)]TJ
/F8 1 Tf
9.8625 0 TD
[(in)-451.1(postpartum)-450.8(breast)-455.4(ab-)]TJ
-13.6562 -1.1284 TD
(scesses.)Tj
/F4 1 Tf
3.4705 0 TD
[(Breastfeed)-336.3(Med)]TJ
/F8 1 Tf
6.7397 0 TD
(2010;5:113115.)Tj
-11.9606 -1.1223 TD
[(24.)-500.5(Chen)-302.3(CY,)-299.5(Anderson)-301.1(BO,)-299.5(Lo)-294.9(SS,)-298.9(et)-296.7(al.)-302.8(Methicillin-resistant)]TJ
/F4 1 Tf
1.7505 -1.1284 TD
[(Staphylococcus)-651.2(aureus)]TJ
/F8 1 Tf
10.2467 0 TD
[(infections)-643.9(may)-644.6(not)-646.4(impede)-642.6(the)]TJ
-10.2467 -1.1223 TD
[(success)-401.3(of)-393(ultrasound-guided)-403.3(drainage)-393.7(of)-399.1(puerperal)-396.1(breast)]TJ
0 -1.1284 TD
(abscesses.)Tj
/F4 1 Tf
4.4158 0 TD
[(J)-339.8(A)0(m)-333.1(Coll)-333.6(Surg)]TJ
/F8 1 Tf
6.7336 0 TD
(2010;210:148154.)Tj
-12.8999 -1.1223 TD
[(25.)-500.5(Dabbas)-357.6(N,)-355.5(Chand)-357.4(M,)-359.3(Pallett)-351.6(A,)-355.6(et)-357.7(al.)-357.7(Have)-358.2(the)-351.7(organisms)]TJ
1.7505 -1.1284 TD
[(that)-247.6(cause)-244.2(breast)-241.9(abscess)-248.9(changed)-245.4(with)-245(time?Implications)]TJ
0 -1.1223 TD
[(for)-389.3(appropriate)-383.7(antibiotic)-385.1(usage)-386.4(in)-384(primary)-387(and)-382.8(secondary)]TJ
0 -1.1284 TD
(care.)Tj
/F4 1 Tf
2.2628 0 TD
[(Breast)-334(J)]TJ
/F8 1 Tf
3.7266 0 TD
(2010;16:412415.)Tj
-7.7399 -1.1223 TD
[(26.)-500.5(Johnson)-249.3(MD,)-239.1(Decker)-249.2(CF.)-245.9(Antimicrobial)-248.8(agents)-245.7(in)-243.7(treatment)]TJ
1.7505 -1.1284 TD
[(of)-338.1(MRSA)-332.3(infections.)]TJ
/F4 1 Tf
8.8683 0 TD
[(Dis)-329.9(Mon)]TJ
/F8 1 Tf
3.8852 0 TD
(2008;54:793800.)Tj
-14.504 -1.1223 TD
[(27.)-500.5(Rodvold)-444.4(KA,)-448.8(McConeghy)-440.7(KW.)-445.4(Methicillin-resistant)]TJ
/F4 1 Tf
24.1103 0 TD
(Sta-)Tj
-22.3598 -1.1284 TD
[(phylococcus)-309.7(aureus)]TJ
/F8 1 Tf
8.2828 0 TD
[(therapy:)-309.6(Past,)-305.2(present,)-303.1(and)-303.5(future.)]TJ
/F4 1 Tf
13.9672 0 TD
(Clin)Tj
-22.25 -1.1223 TD
[(Infect)-339.8(Dis)]TJ
/F8 1 Tf
4.3488 0 TD
[(2014;58\(Suppl)-329.2(1\):S20S27.)]TJ
-6.0992 -1.1284 TD
.0189 Tc
[(2)18.9(8)18.9(.)-481.6(D)-7.2(i)1(ns)-4.8(moor)-373.9(M)-4.9(J)1.4(,)-377.6(V)-1.1(ilo)-5.6(ria)-375.8(R)1.8(,)-377.6(L)-1.4(ief)-373.9(L)-1.4(,)-371.5(e)-3.7(t)-371(a)-3.7(l.)-371.5(Us)-4.7(e)-375.8(o).5(f)-373.9(i)1(nt)-5.1(rap)-5.6(a)2.4(r-)]TJ
1.7505 -1.1223 TD
[(t)-5(u).6(m)-395.4(a)-3.6(nt)-5(ibi)-5(o).6(ti)-5(cs)-401.1(and)-395.9(t)-5(he)-394(i)-5(n).6(cidence)-400.1(o).6(f)-398.2(p).6(o)-5.5(s)1.4(tn)-5.5(at)-5(al)-401.4(maternal)]TJ
0 -1.1284 TD
.0204 Tc
[(and)-626.3(n)2(eonatal)-619.6(y)2(east)-625.7(i)2.5(nfections.)]TJ
/F4 1 Tf
14.1563 0 TD
.0198 Tc
[(Obstet)-626.3(Gynecol)]TJ
/F8 1 Tf
7.4594 0 TD
.0184 Tc
[(200)-6.1(5;)]TJ
-21.6157 -1.1284 TD
[(1)-6.1(06:)-5.6(192)-6.1(2.)]TJ
-1.7505 -1.1223 TD
0 Tc
[(29.)-500.5(Pirotta)-417.4(MV,)-409.9(Gunn)-410.8(JM,)-407.4(Chondros)-409.9(P.)-411.8()52.4(Not)-412.6(thrush)-410.4(again!)53.6()]TJ
1.7505 -1.1284 TD
[(Womens)-266.8(experience)-268.2(of)-264.9(post-antibiotic)-270.9(vulvovaginitis.)]TJ
/F4 1 Tf
22.1951 0 TD
(Med)Tj
-22.1951 -1.1223 TD
[(J)-333.7(Aust)]TJ
/F8 1 Tf
2.8971 0 TD
(2003;179:4346.)Tj
-4.6476 -1.1284 TD
[(30.)-500.5(Am)16.9(ir)-239.9(LH)20.7(,)-244(F)0(o)15.1(r)0(s)22.7(t)0(e)20.5(r)-252.5(D,)-233.6(Mc)14.5(La)24.1(ch)13.8(l)12.6(a)0(n)-236.3(H)0(,)-239.7(e)0(t)-235.7(a)0(l)14.4(.)-244(In)21.8(ci)14.4(de)19.9(nc)19.9(e)-248.3(o)0(f)-234.4(b)0(r)15.7(e)0(a)21.8(s)0(t)]TJ
1.7505 -1.1223 TD
.0108 Tc
[(abscess)-464.2(i)10.8(n)-470.7(l)-1(actat)10.8(i)-6.6(n)-1.5(g)-459(w)-3.1(om)10.8(e)-5.5(n)-1.5(:)-464.5(R)-.2(eport)-464.5(from)-464.6(a).4(n)-459(A)-3.1(us)10.8(t)-6.3(r)2.2(alian)]TJ
0 -1.1284 TD
.0128 Tc
[(coho)6.6(rt)12.8(.)]TJ
/F4 1 Tf
3.2204 0 TD
.0093 Tc
[(BJO)-4.6(G)]TJ
/F8 1 Tf
2.8727 0 TD
.0122 Tc
[(2)6(0)-.1(0)6(4)-.1(;1)6(11:)12.2(1)-5.8(3)-.1(7)6(8)-.1()6(138)6(1.)]TJ
-7.8436 -1.1223 TD
0 Tc
[(31.)-500.5(Dixon)-367.7(JM.)-364.7(Repeated)-363.8(aspiration)-369.4(of)-362.5(breast)-363.9(abscesses)-368.3(in)-359.6(lac-)]TJ
1.7505 -1.1284 TD
[(tating)-338.8(women.)]TJ
/F4 1 Tf
6.1602 0 TD
(BMJ)Tj
/F8 1 Tf
2.2262 0 TD
(1988;297:15171518.)Tj
-10.1369 -1.1223 TD
[(32.)-500.5(Ulitzsch)-386.7(D,)-379.9(Nyman)-384.2(MKG,)-381.1(Carlson)-382.9(RA.)-384.9(Breast)-387(abscess)-383(in)]TJ
1.7505 -1.1284 TD
[(lactating)-505.7(women:)-493.6(US-guided)-499.7(treatment.)]TJ
/F4 1 Tf
17.0718 0 TD
(Radiology)Tj
/F8 1 Tf
4.6232 0 TD
(2004;)Tj
-21.695 -1.1223 TD
(232:904909.)Tj
-1.7505 -1.1284 TD
-.0225 Tc
[(3)-22.5(3)-22.5(.)-523(C)-3(h)-4.3(ri)-3.8(st)-3.8(en)-4.3(sen)-242.2(A).2(F,)-242.1(A)-5.9(l)2.3(-S)-7.2(ul)-3.8(im)-3.9(an)-242.2(N,)]TJ
14.0587 0 TD
-.0202 Tc
[(Nielson)-233.8(K)-3.6(R,)-233.7(et)-239.3(al.)-239.8(U)2.5(ltra)5.9(sound-)]TJ
-12.3083 -1.1223 TD
-.0192 Tc
[(gu)5.1(ided)-360.9(drain)5.1(a).9(ge)-365.1(o)5.1(f)-369.3(b)5.1(r)2.7(east)-366.4(a).9(b)5.1(s)-.2(cesses)5.9(:)-366.4(Resu)5.1(lt)5.6(s)-366.1(i)-.5(n)-367(1)5.1(51)-360.9(pat)5.6(i)-.5(ent)5.6(s)-.2(.)]TJ
/F4 1 Tf
0 -1.1284 TD
-.0177 Tc
[(Br)-328(J)-333.1(R)4.7(ad)6.6(io)6.6(l)]TJ
/F8 1 Tf
4.9404 0 TD
-.0182 Tc
[(2)6.1(0)0(0)6.1(5)0(;)6.6(78:)6.6(18)6.1(6)6.1(18)6.1(8.)]TJ
-6.6909 -1.1223 TD
0 Tc
[(34.)-500.5(Ka)18.3(ta)14.4(ri)22.4(a)-260.5(K)0(,)-251.9(S)0(r)18.9(i)12.6(va)19.9(st)19.5(av)19.9(a)-260.5(A)0(,)-251.9(D)0(h)22.5(a)0(r)-250.8(A)0(.)-251.9(M)12.8(an)13.8(a)14(g)0(e)13.8(m)12.5(en)19.9(t)-261.8(o)0(f)-246.6(l)0(a)20.5(c)0(t)14.4(a)14(ti)19.2(on)18(al)]TJ
1.7505 -1.1284 TD
[(ma)14.2(s)12.9(t)0(i)19.2(t)0(i)19.2(s)-359.1(an)19.9(d)-360(b)0(r)15.7(e)0(a)21.8(s)0(t)-352.6(a)0(b)19.9(s)0(c)20.8(e)0(s)14.7(s)12.9(es)14.7(:)-359.4(r)0(e)17.6(v)0(i)24.7(e)0(w)-353.7(o)0(f)-350.3(c)0(u)19.9(r)0(r)19.5(e)0(n)19.9(t)-359.4(kn)18(ow)16.4(l)12.6(e)0(d)19.9(g)0(e)]TJ
0 -1.1223 TD
-.0209 Tc
[(a)-20.9(n)-7.1(d)-344.3(p)-20.9(ra)-20.9(ct)-20.9(ic)-20.9(e)-5.2(.)]TJ
/F4 1 Tf
5.4344 0 TD
0 Tc
[(In)21.8(di)18.6(an)-317.4(J)-321.5(S)0(u)18(r)12.9(g)]TJ
/F8 1 Tf
5.837 0 TD
[(20)18(13)18(;)12.6(7)0(5)18(:)12.6(43)18(0)18(43)24.1(5.)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(242)Tj
46.3849 0 TD
[(ABM)-336(PROTOCOL)]TJ
ET
endstream
endobj
120 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 122 0 R/MediaBox[0 0 612 792]/Annots[123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R 129 0 R 130 0 R 131 0 R 132 0 R 133 0 R 134 0 R 135 0 R 136 0 R 137 0 R 138 0 R 139 0 R 140 0 R]/Rotate 0>>
endobj
141 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
121 0 obj
<>stream
/GS1 gs
BT
/F8 1 Tf
9.2951 0 0 9.2951 59.7543 725.1588 Tm
0 0 0 1 k
0 Tc
0 Tw
[(35.)-500.5(Livingstone)-529.6(V,)-532.4(Stringer)-530.2(LJ.)-525.9(The)-531.1(treatment)-532.5(of)]TJ
/F4 1 Tf
21.8841 0 TD
(Staphylo-)Tj
-20.1336 -1.1223 TD
[(coccus)-421.3(aureus)]TJ
/F8 1 Tf
6.2822 0 TD
[(infected)-423.6(sore)-421(nipples:)-417.5(A)-416.5(randomized)-424(com-)]TJ
-6.2822 -1.1284 TD
[(parative)-338.2(study.)]TJ
/F4 1 Tf
6.3249 0 TD
[(J)-333.7(Hum)-332.9(Lact)]TJ
/F8 1 Tf
5.1661 0 TD
(1999;15:241246.)Tj
-13.2414 -1.1223 TD
.0115 Tc
[(3)11.5(6)11.5(.)-489(Am)11.5(i)-6.1(r)-509.4(LH,)-507(G)-2.4(arland)-507.1(SM,)-507(D)-2.4(enners)11.5(t)-5.6(e)1.1(in)-507.1(L,)-507(et)-512.6(al)11.5(.)]TJ
/F4 1 Tf
22.2195 0 TD
.0118 Tc
[(Ca)5.6(ndi)11.8(d)-6.2(a)]TJ
-20.469 -1.1283 TD
.0076 Tc
[(a)-4.7(l)-4.2(bi)-4.2(ca)-4.7(ns)]TJ
/F8 1 Tf
3.4766 0 TD
.0113 Tc
[(:)-518.9(I)2.7(s)-518.6(i)-.5(t)-518.9(a).9(ss)11.3(o)-6.4(c).9(iated)-513.4(w)-2.6(it)11.3(h)-525.1(n)-1(i)11.3(p)-6.7(pl)11.3(e)-529.3(p)5.1(ain)-519.5(i)11.3(n)-525.1(l)-.5(actati)11.3(n)-6.7(g)]TJ
-3.4766 -1.1223 TD
.0125 Tc
[(wo)6.3(men?)]TJ
/F4 1 Tf
3.7876 0 TD
.011 Tc
[(Gynecol)-336.2(O)3.2(bst)11(e)-5.1(t)-336.2(I)2.4(nvest)]TJ
/F8 1 Tf
9.5453 0 TD
.0123 Tc
[(19)6.1(96;)12.3(4)-5.7(1)0(:)12.3(3)-5.7(0)6.1(34)6.1(.)]TJ
-15.0834 -1.1284 TD
0 Tc
[(37.)-500.5(Saenz)-790.8(RB.)-784.5(Bacterial)-792(pathogens)-789(isolated)-787.7(from)-785.5(nipple)]TJ
1.7505 -1.1223 TD
[(wounds:)-507.4(A)-507.9(four-year)-506.9(prospective)-508.5(study.)]TJ
/F4 1 Tf
17.4011 0 TD
[(Breastfeed)-507.1(Med)]TJ
/F8 1 Tf
-17.4011 -1.1284 TD
(2007;2:190.)Tj
-1.7505 -1.1223 TD
-.0285 Tc
[(3)-28.5(8)-28.5(.)-529(Hale)-313.4(TW)3.6(,)-315.2(B)3.2(ate)3.8(m)2.3(an)-309.2(TL,)-315.2(F)5.1(i)2.4(nke)3.8(l)2.4(man)-309.2(M)-3.5(A,)-309.1(et)-308.6(al.)-309.1(T)0(he)-313.4(absenc)3.8(e)-313.4(o)1.9(f)]TJ
/F4 1 Tf
1.7505 -1.1284 TD
-.0299 Tc
[(Candida)-518(albicans)]TJ
/F8 1 Tf
7.4289 0 TD
-.0307 Tc
[(in)-512.7(m)-6(ilk)-518.8(sam)-6(p)-.3(les)-517.9(o)-.3(f)-515(w)-1.9(om)-6(en)-518.8(with)-518.8(clin)-6.4(ical)]TJ
-7.4289 -1.1223 TD
-.0298 Tc
[(s)-4.7(y).6(mptoms)-687.8(o)-5.5(f)-684.9(ductal)-688.1(c)2.5(andidiasis)-4.7(.)]TJ
/F4 1 Tf
14.0343 0 TD
-.0318 Tc
[(Br)-6.7(eas)-6.7(tfe)-5.6(ed)-690.7(Med)]TJ
/F8 1 Tf
7.0568 0 TD
-.0305 Tc
[(2009)-6.2(;4:)]TJ
-21.0912 -1.1284 TD
[(576)-6.1(1.)]TJ
-1.7505 -1.1284 TD
.0211 Tc
[(3)21.1(9)21.1(.)-479.4(Andrews)-460(J)3.6(I,)-460.8(Flee)4.6(ne)4.6(r)-463.2(DK,)-460.8(Mes)3.6(s)-2.5(er)-457.1(SA,)-460.8(e)4.6(t)-460.3(a)-1.5(l.)-460.8(The)-465.1(y)2.7(ea)4.6(st)]TJ
1.7505 -1.1223 TD
.0197 Tc
[(con)-4.8(n)1.3(ect)-4.3(i)1.8(on:)-455.6(Is)]TJ
/F4 1 Tf
6.5689 0 TD
.018 Tc
[(Ca)-6.5(ndi)-6(da)]TJ
/F8 1 Tf
4.0377 0 TD
.0209 Tc
[(linked)-448.9(t)3(o)-455(b)2.5(re)4.4(astfee)4.4(ding)-448.9(as)3.4(soci-)]TJ
-10.6066 -1.1284 TD
.0204 Tc
[(ated)-351.8(pain?)]TJ
/F4 1 Tf
4.733 0 TD
.0196 Tc
[(Am)-354.2(J)-350.7(O)-.4(bs)-4(tet)-352(G)-.4(ynecol)]TJ
/F8 1 Tf
9.4599 0 TD
.0184 Tc
[(20)-6.1(07;)-5.6(197:)-5.6(424.)-6.1(e1)-6.1(e4.)]TJ
-15.9434 -1.1223 TD
0 Tc
[(40.)-500.5(Panjaitan)-271.3(M,)-261.7(Amir)-265.7(LH,)-266.1(Costa)-264.4(A-M,)-265.9(et)-260.1(al.)-266.3(Polymerase)-267.5(chain)]TJ
1.7505 -1.1284 TD
[(reaction)-332.1(in)-329.1(detection)-335.5(of)]TJ
/F4 1 Tf
9.8564 0 TD
[(Candida)-328.5(albicans)]TJ
/F8 1 Tf
7.5021 0 TD
[(for)-328.3(conrmation)]TJ
-17.3584 -1.1223 TD
[(of)-606.4(clinical)-609.2(diagnosis)-600.3(of)-606.4(nipple)-601.7(thrush.)]TJ
/F4 1 Tf
17.2974 0 TD
[(Breastfeed)-610.8(Med)]TJ
/F8 1 Tf
-17.2974 -1.1284 TD
(2008;3:185187.)Tj
-1.7505 -1.1223 TD
[(41.)-500.5(Amir)-393.8(LH,)-394.2(Donath)-390.3(SM,)-392.9(Garland)-390.9(SM,)-392.9(et)-394.3(al.)-388.2(Does)]TJ
/F4 1 Tf
22.2805 0 TD
(Candida)Tj
/F8 1 Tf
-20.53 -1.1284 TD
(and/or)Tj
/F4 1 Tf
2.8483 0 TD
(Staphylococcus)Tj
/F8 1 Tf
6.5262 0 TD
[(play)-284.8(a)-284.9(role)-287.1(in)-286.4(nipple)-290.6(and)-285.2(breast)-284.6(pain)]TJ
-9.3745 -1.1223 TD
[(in)-323(lactation?)-327(A)-325(cohort)-324(study)-322.5(in)-323(Melbourne,)-321.9(Australia.)]TJ
/F4 1 Tf
22.0792 0 TD
(BMJ)Tj
-22.0792 -1.1284 TD
(Open)Tj
/F8 1 Tf
2.5007 0 TD
(2013;3:e002351.)Tj
22.7623 25.8851 TD
[(42.)-500.5(Collignon)-565.5(PJ,)-563.5(Grayson)-563.3(ML,)-562.6(Johnson)-566.5(PDR.)-564.8(Methicillin-)]TJ
1.7505 -1.1223 TD
(resistant)Tj
/F4 1 Tf
3.812 0 TD
[(Staphylococcus)-480.4(aureus)]TJ
/F8 1 Tf
9.9052 0 TD
[(in)-475.4(hospitals:)-471.2(Time)-475.3(for)-474.7(a)]TJ
-13.7172 -1.1284 TD
[(culture)-333.9(change.)]TJ
/F4 1 Tf
6.5506 0 TD
[(Med)-336.5(J)-333.7(Aust)]TJ
/F8 1 Tf
5.0075 0 TD
(2007;187:45.)Tj
-13.3085 -1.1223 TD
[(43.)-500.5(Kvist)-335.7(LJ.)-342.9(Toward)-340.2(a)-339.8(clarication)-344.7(of)-338.1(the)-339.5(concept)-342.4(mastitis)-342.4(as)]TJ
1.7505 -1.1283 TD
[(used)-510.1(in)-512(empirical)-514.2(studies)-514.6(of)-508.8(breast)-516.4(inammation)-516.6(during)]TJ
0 -1.1223 TD
(lactation.)Tj
/F4 1 Tf
4.0499 0 TD
[(J)-333.7(Hum)-332.9(Lact)]TJ
/F8 1 Tf
5.1661 0 TD
(2010;26:5359.)Tj
9.843 0 0 9.843 320.8251 646.4691 Tm
[(ABM)-184.7(protocols)-195.4(expire)-187.6(5)-191.2(years)-191.9(from)-189.9(the)-188.9(date)-185.4(of)-192.2(publication.)]TJ
-1.0137 -1.1116 TD
[(Evidence-based)-183.6(revisions)-183.7(are)-184.1(made)-180.8(within)-186.4(5)-179.6(years)-180.4(or)-180.7(sooner)-186.1(if)]TJ
T*
[(there)-278.6(are)-287.8(signicant)-278.3(chang)-7.8(es)-279.6(in)-278.8(the)-281.1(evidence.)]TJ
0 -2.3269 TD
-.0203 Tc
[(The)-304.8(A).8(ca)-5.3(dem)-5.3(y)-297.9(of)-303.6(Bre)-5.3(a).5(stfe)-5.3(eding)-297.9(M)-5(edicine)-299(P)-4(rotocol)-298(C).6(ommitte)-5.3(e)]TJ
/F4 1 Tf
4.3083 -1.1174 TD
0 Tc
[(Kathleen)-335(A.)-334(Marinelli,)-338.4(MD,)-335.9(FABM,)-335(Chairperson)]TJ
-.7603 -1.1116 TD
[(Maya)-334.9(Bunik,)-334(MD,)-335.9(MSPH,)-333.5(FABM,)-340.8(Co-Chairperson)]TJ
-.6796 -1.1116 TD
[(Larry)-340.2(Noble,)-333.8(MD,)-335.9(FABM,)-335(Translations)-335.4(Chairperson)]TJ
14.1631 -1.1174 TD
[(Nancy)-331.4(Brent,)-339.5(MD)]TJ
-1.3593 -1.1116 TD
[(Amy)-340.6(E.)-334(Grawey,)-336.6(MD)]TJ
-6.6755 -1.1116 TD
[(Alison)-336.2(V.)-334(Holmes,)-335.4(MD,)-335.9(MPH,)-332.4(FABM)]TJ
2.5228 -1.1174 TD
[(Ruth)-334(A.)-334(Lawrence,)-339(MD,)-330.1(FABM)]TJ
2.373 -1.1116 TD
[(Tomoko)-336.8(Seo,)-336.2(MD,)-330.1(FABM)]TJ
/F8 1 Tf
-5.0225 -2.9317 TD
[(For)-337.2(correspondence:)-339(abm@bfmed.org)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(ABM)-336(PROTOCOL)]TJ
53.0113 0 TD
(243)Tj
ET
endstream
endobj
142 0 obj
[/Indexed/DeviceRGB 255 143 0 R]
endobj
143 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
144 0 obj
<>
endobj
35 0 obj
<>
endobj
145 0 obj
<>stream
hޤU{PT9lԬx)hbB bDPP
cvAX VBQѨILLVAhʤ~|]4N2w~}W!BRErcb#%FAp6PT7Uq3L:s6`J2jclcEl2glaVDhFќ+GsizmEfcFkJFeYFmZ}aɬMs-9I4CޜfL^hA+a LQsB$b(eJp *'$)-ukvS++UbջvM2dTCuI=ǻi[sNrQlB#yLIIP0zDXH9=\GF"=d`= YD=i8^NJ 4vƢ~Mc sF<uE
O
jІ0Rxޜl~7Vp̓/-yzSA"՜"$g2'ތX32j
!¤@9wEkޗ)au/E֕jJ8֕ڷ^>3瓦ώ|8C @ 3:aLV,\V`"iޠ2俦/ZD'Oũ3w70$~̔F;yU
OZٍ;Pk K{Sku0#gm-E7XWZR=yݟf:c<
YC-^FJJ70kqecoO =\$N\>El5YsbjwnRk]= _0B_sP,jRsBZ2ȩ,v!q/3BJB[އFq\݆n`5PçSݚ1_,?y
ֵ_kXoH1c_:G:Ӽ[;dj08j#JeYw}7H`P(5..yRX|$ap}įoھ[7ׯ`OظGVZ.گKyYUn\ݤf+iKRguI-K.ZZN4?K:i~()T5
%9$ʖb!*r[BgJBLCAH"7a3W,8=
xu2cż>Ú䦠rAbcG4Z@!OPEq7BJ?CAO Djl5:po]ƧEL:m]jUbX^99<%e!8zv<$d9H0ɋt\nqGU^2OttAlw}xW4x'^z2,Px#?u
ڬ؏7dMgk m%KʊXIJ79 R6Nig~lo<[xAXK%}w=zbs$×/&{3h=dC;3Z47z/3|_^]@Yz?3cHDZdk;i(~C"moe+r%N9_/F* 'EQ2'?*R'xX{'svS4kt4JROy'b$6^
Ax\60QQ4SM m{Bb'#$(,`[,y[+<TcS
RU
0?9u+x+d,#? I#4
endstream
endobj
42 0 obj
<>
endobj
146 0 obj
<>stream
8;Z\7>EXX^&G%UTp&34"l`:L',EI:6m:t/gMjc5'kn$2^i5#F*Xn6=7p9j6>b6n]$
DtK*(]:%DtXCAG9CV:Ih?N_\$jgJ;=[F\]RqhDgCY9A6&eU,KYp.HH2'*gjVDp1"VH:_&`^-4;5c1Fmk;\In5PSnX'
9p<6c&'nt3qjf!=F/;^b^WCmD4["d@3<]YqMLoC]L.5&$4dpkKCeOWF1EBu`cG?)S
X]dI0A&-D[m'=maPFc.55iq+cXlYoIgrCp7:]ICaW!Y12AIf;I::33!]m;=Im/EU>
2-$MbY#RVrI:TDPMXkaLJnV%_62g9nB]N1F6mbgsi7J9XNd"LV2ZpN(/@$hjL5
B4t\%q,GqX,HC#+TUu(-Q(FuVb+DO/bf@m52NJIr[DJ^0,UiXiY.hA#Eb^)bWALSd
aS'ChGCC(l2ZV?T",[~>
endstream
endobj
38 0 obj
<>stream
8;Z\66'?jS%-qE5jo98hGIBbf@*:=&L@,(bf\$m0'Lc%Ro&'r1E9]Ba%B[$a3g\dT
fOl'<4FT5mp$SE4@AhuT^=D$)4WKDn5h18\c4le8I[I=/WKgaub"llWXQdl%F"sU;
MuOchR9/5,T2*X&dJ\:5bC*I3?NH>hWmkfh\a3;[KM_E.@Q@cL?h@Td1f4W[Z'24$
l%N5R7jKF\Li`X@"58QIO!AEMt'h5%FK1#2Pid.#:nbgP'EZ\:-
ZFnUeNc`]>8?"&IOKeoWSOr+SY260(:dmU`;@%a>qb-:dW7:JT5nb!q"S\8N5Ru;u
RA9n7.Xh5-6j[nL@Hn/.rRIO(qolA++YPjm!`Pl$KDnR7@f$;<&q?0j]7K,!/8n-a`R,Q>"EFdF.ED]e'Wg,!k)n3,$o#5g@Aa>3`F]kB?E1fkJ"N)$HP
^@>:@_S(=&qCC>i3%%#!O1#6gql:@6$H2&F4=$mihQ+RN^;!>^3#1rW56+D7ok]&1
\Y)r2FEG+Eq>X]K'ec:4^B,Fk(t%ZcK+Iqc!:@'YZN~>
endstream
endobj
44 0 obj
<>stream
8;Z\7D6h&%#g?`Rchj>glh!%V7M-D59P<4(4&47f+Kd4+U)sT$dOQ>JjOsXWr.c'or/)Cq.ii5<%-^Q(
Id!OKO1q\XJaLZ_3]k]O3@aq'3;DLm)8<8'EaP]na*)&E3gtS1h*8'F[I_4Hhe8C!
Z")%iF*T62T<>B&0IL8mSm^?tQdL:k].Ydtm[rR`':78,J%n1imuQ*Ro;*l!k%idn
Ie\tK%fdeuUfR~>
endstream
endobj
50 0 obj
<>stream
8;Z\79B$ubF+_97,SsYB*T))53mo%=&i@Kge
+\*Pjm__/t&/`;2kOlk@rit+B<^(0rd1BB:Y>$D4R9dZ\?PE<=::BdTbEp,9R9$Oj
YE/S&20@G0M@,\npke,O+-u!_+CB.EF20mq(-@.oDJhq>(BBmioJ@=ZApC@9Q4
ETepDQ/@FiVN,Gp6hN(RL,Tu50]PTECVBRVPY^[pXK?0>u3S7
eR'*8FH$+KQ%en&MKBm0o+ArRUE!%Y9/-gTb8NqWf/Fr!=-16q7fhN)W7F!EjfU[=
7^GV=ccOIUpsM<,X/Dm\ZcM_7\=Ti4="kK_jnP1he>U)h$+lo.V-;VR`-X]bQh.@6
bG=9..tU*aq1;#sic=g/?2Zf71;BTtc*&3.$a,7NkmO'YW-;#m<."F,^A-=*=oUUm
(@fo4C,3%c1Ws1a?QKkJq.Ocu%`*7`@/=%uP/J+2'!24AIGFYh=P5).(cAhYYFS$f
P0s4GM",V8`>b$);EO_a^S8HhpF!,I^qVol'^C'OO?Q2(7(`pBrOI`_^\@\bAnJDo
T`+h-_HZmQ<+d8he$HQE5kGdK=cpieY$.As7X?/3ojud#nICYT)YAmDpX:-H,/2:5
9&N4dqMJ,rI9#+N'@2.m/hQ$&?fJcP8jH07dDXoB!Eqc^~>
endstream
endobj
122 0 obj
<>stream
8;Z\u;%gbh#Xia$rd"OMluearUSpF7A(m"3lT"9f&_I'ea:1I\Kt-P5]0;f6#TL3[
IWdfASbS2nrZH)`J8JCl?/a;Q,#AMeB8d_*af;]hfF)e>#nJgE$BdHJTZ&g6@
;QG$W^/;rD1Gg+E>dhnYY8'?k8m+6BFWY65ngqu!`I*kb72>u>*f;,mQ)ph8]A1,h
dAp:sTM[%AQrGPJd^e&8Vbju[X`QhP0Z[DJh;qB;!alV#Rb.s5I)
V)q^i>Xk+`W"giGgAclP:K:&:$;G.CAq#C-*`G!AG9g^IeITahmAsX7c%i1A.&Xdq
7\^fgX+V$N#U+j463naqhfoY3=Us;3~>
endstream
endobj
147 0 obj
<>
endobj
148 0 obj
<>
endobj
29 0 obj
<>
endobj
150 0 obj
<>
endobj
149 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 146 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
163 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
159 0 obj
<>
endobj
32 0 obj
<>
endobj
160 0 obj
<>
endobj
34 0 obj
<>
endobj
36 0 obj
<>
endobj
161 0 obj
<>
endobj
43 0 obj
<>
endobj
37 0 obj
<>
endobj
165 0 obj
<>
endobj
167 0 obj
<>
endobj
168 0 obj
<>
endobj
171 0 obj
<>
endobj
31 0 obj
<>
endobj
170 0 obj
<>
endobj
151 0 obj
<>stream
HlTK6Wȅ*bzMEXB.A\2DCͿIN0H{Yu\w=XvLNʪ_YJŨWF*SU?|~wcBSFP
éjRN6C5o8ռ6%9V"rȻ`O7T
!55ӎ3ʚTo h_˜|p~u#n%`?ex
H%apG;u[`03ۿj3!L#_Ұ,[S-qR;0JaaoyYǪvF/n~0 CT uC%`{ed>f
yݐ'XENwahѹb,7rZuҔ3Y\japs\0ljri
" bTnb
HM+*k-*kM<*KfS@{~Fb-\ݫ;[ڒFΥ!!,Duі9i
`27
ڇ~A瓛Sw _lgbubi|Uje[Wڷ\|]-nV28vݘ/~t[(l!n`1M[5vS // Vcbc ~s29\lLܲ賖pN'pY!p,nhFK';\$0}.c
[!Ckp47|ч9q{4|K[I%`F0-ኘjB(5
VѿbOHr@ʃJ4e9 0 ũ
endstream
endobj
152 0 obj
<>stream
HtU͎6SYDO\@~S#k%hPn}/whv;i5-. 7f7ܱ͑[Љ$o24ZKv'tQ$Erͺ<PW}-7H)P5!j?R@NO!<꽹xmt%,&hs;% K;<`P-A=˾X+VTu-<]+4gJ/:Pv)l_=7霠ZP{6~|P>{Ai|dY>PdyϱP+i`|:r8OǕ4G
J7:|B.6=}KdMUℸV̹B[+Nf
DQe8NFi^GpQ@8&WX[E%Rh`P/.؏ %S/!L.iJtGRADD::%Ȓ"`dBwK